nct_id,title,overall_status,study_type,completion_date,lead_sponsor,lead_sponsor_class,collaborator,collaborator_class,phase,locations,has_drug_intervention,drugs,disposition_date,results_date,enrollment,phase_normalised,is_completed,is_overdue,pubmed_results
NCT00000202,Buprenorphine Maintenance for Opioid Addicts - 1,Completed,Interventional,2006-05-01,Yale University,Other,National Institute on Drug Abuse (NIDA),NIH,2,United States,True,Buprenorphine; ,,,0.0,2,True,True,False
NCT00000203,Buprenorphine Maintenance for Opioid Addicts - 2,Completed,Interventional,2006-05-01,Yale University,Other,National Institute on Drug Abuse (NIDA),NIH,2,United States,True,Buprenorphine; ,,,0.0,2,True,True,False
NCT00000204,Buprenorphine Maintenance for Opioid Addicts - 3,Completed,Interventional,2006-05-01,Yale University,Other,National Institute on Drug Abuse (NIDA),NIH,2,United States,True,Buprenorphine; ,,,0.0,2,True,True,False
NCT00033917,Indomethacin Germinal Matrix Hemorrhage/Intraventricular Hemorrhage (GMH/IVH) Prevention Trial,Completed,Interventional,2012-03-01,Yale University,Other,,,3,United States,True,indomethacin; placebo; ,,2013-01-08,630.0,3,True,False,False
NCT00076687,Safety Study of Botulinum Toxin Type A in Post-Upper Limb Stroke Patients With Reduced Lung Function,Completed,Interventional,2009-08-01,Allergan,Industry,,,2,Czech Republic Hungary Poland United States,True,saline; ,,2011-07-28,155.0,2,True,False,False
NCT00080145,RUPP PI PDD: Drug and Behavioral Therapy for Children With Pervasive Developmental Disorders,Completed,Interventional,2007-09-01,Yale University,Other,National Institute of Mental Health (NIMH),NIH,,United States,True,Risperidone; ,,,124.0,5,True,False,True
NCT00105144,Study of Micafungin in Patients With Invasive Candidiasis or Candidemia,Completed,Interventional,2006-04-01,Astellas Pharma Inc,Industry,,,3,Austria Belgium Brazil Canada Croatia Czech Republic France Germany India Netherlands Poland Spain Switzerland United Kingdom United States,True,Micafungin; Caspofungin; ,,,611.0,3,True,False,True
NCT00105482,Targeted Interventions for Weight-Concerned Smokers,Completed,Interventional,2009-04-01,Yale University,Other,National Institute on Alcohol Abuse and Alcoholism (NIAAA),NIH,2,United States,True,Naltrexone; Transdermal nicotine replacement; ,,2013-01-28,172.0,2,True,False,False
NCT00106392,A Safety and Efficacy Study of Prograf in the Prevention of Erectile Dysfunction After Radical Prostatectomy,Completed,Interventional,2008-04-01,Astellas Pharma Inc,Industry,,,4,United States,True,Tacrolimus; Placebo; ,,2010-09-30,131.0,4,True,False,False
NCT00106496,A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis,Completed,Interventional,2006-07-01,Astellas Pharma Inc,Industry,,,4,United States,True,Protopic; Corticosteroid; placebo; ,,,410.0,4,True,True,False
NCT00113269,"Safety/Efficacy of Induction Agents With Tacrolimus, MMF, and Rapid Steroid Withdrawal in Renal Transplant Recipients",Completed,Interventional,2009-03-01,Astellas Pharma Inc,Industry,,,4,United States,True,basiliximab; rabbit anti-thymocyte globulin; tacrolimus; alemtuzumab; mycophenolate mofetil; steroids; ,,2011-06-07,501.0,4,True,False,False
NCT00125320,Response to RSD1235 Compared to Placebo in Subjects With Atrial Arrhythmia After Heart Surgery,Completed,Interventional,2007-02-01,Astellas Pharma Inc,Industry,"Astellas Pharma US, Inc. Cardiome Pharma",Industry Industry,3,Argentina Canada Denmark India Poland United States,True,RSD1235; ,,,190.0,3,True,False,True
NCT00129311,Usefulness of Selegiline as an Aid to Quit Smoking - 1,Completed,Interventional,2012-12-01,Yale University,Other,National Institute on Drug Abuse (NIDA),NIH,2,United States,True,Selegiline; Placebo; ,,2014-06-16,101.0,2,True,False,False
NCT00141882,Memantine in Patients With Chronic Glaucoma,Completed,Interventional,2006-01-01,Allergan,Industry,,,3,,True,memantine; ,,,1119.0,3,True,True,False
NCT00142909,Effectiveness of Lofexidine to Prevent Stress-Related Opiate Relapse During Naltrexone Treatment - 1,Completed,Interventional,2009-01-01,Yale University,Other,National Institute on Drug Abuse (NIDA),NIH,2,United States,True,Lofexidine; Placebo; ,,2012-11-01,86.0,2,True,False,False
NCT00157014,Canadian Cardiology de Novo Study: A Comparison Between Tacrolimus- and Cyclosporine- Based Immunoprophylactic Regimens,Completed,Interventional,2008-07-01,Astellas Pharma Inc,Industry,"Astellas Pharma Canada, Inc.",Industry,3,Canada United States,True,Tacrolimus; Cyclosporine; Mycophenolate mofetil; Methylprednisolone; Prednisone; ,,2010-10-28,111.0,3,True,False,False
NCT00168298,A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion,Completed,Interventional,2008-03-01,Allergan,Industry,,,3,"Brazil Canada Colombia Hong Kong India Italy Korea, Republic of New Zealand Poland Singapore Spain United Kingdom United States",True,700 µg Dexamethasone; 350 µg Dexamethasone; ,,2009-07-15,668.0,3,True,False,False
NCT00168324,A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Retinal Vein Occlusion,Completed,Interventional,2008-03-01,Allergan,Industry,,,3,Australia Austria Canada Czech Republic France Germany Israel Mexico Philippines Portugal South Africa Taiwan United States,True,700 µg Dexamethasone; 350 µg Dexamethasone; ,,2009-07-15,599.0,3,True,False,False
NCT00168337,A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema,Completed,Interventional,2012-05-01,Allergan,Industry,,,3,"Brazil Canada Colombia France Hungary India Italy Korea, Republic of New Zealand Poland Singapore Taiwan United Kingdom United States",True,Dexamethasone; ,,2014-07-10,554.0,3,True,False,False
NCT00168350,Memantine in Patients With Chronic Glaucoma,Completed,Interventional,2006-09-01,Allergan,Industry,,,3,,True,memantine; ,,,1179.0,3,True,True,False
NCT00168363,Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension,Completed,Interventional,2006-08-01,Allergan,Industry,,,3,,True,brimonidine; ,,,207.0,3,True,False,True
NCT00168389,A Study of the Safety and Efficacy of a New Treatment for Diabetic Macular Edema,Completed,Interventional,2012-06-01,Allergan,Industry,,,3,Australia Canada Czech Republic Germany Israel Philippines Portugal South Africa Spain United States,True,Dexamethasone; ,,2014-07-10,494.0,3,True,False,False
NCT00168454,A Research Study for Patients With Overactive Bladder,Completed,Interventional,2008-01-01,Allergan,Industry,,,2,Belgium Canada Germany Poland United Kingdom United States,True,Placebo; ,,2009-09-02,313.0,2,True,False,False
NCT00189709,Micafungin Versus Fluconazole in the Treatment of Invasive Candidiasis and Candidemia,Completed,Interventional,2006-07-01,Astellas Pharma Inc,Industry,"Astellas Pharma Taiwan, Inc.",Industry,3,Taiwan,True,Micafungin; fluconazole; ,,,24.0,3,True,True,False
NCT00189826,A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Liver Transplantation.,Completed,Interventional,2006-12-01,Astellas Pharma Inc,Industry,,,3,Australia Belgium Brazil Canada Czech Republic Finland France Germany Ireland Italy Norway Poland Spain Sweden Switzerland United Kingdom,True,tacrolimus; ,,,475.0,3,True,True,False
NCT00189839,A Study to Evaluate the Safety and Efficacy of FK506E (MR4) in Patients Undergoing Primary Kidney Transplantation,Completed,Interventional,2006-12-01,Astellas Pharma Inc,Industry,,,3,Argentina Australia Austria Belgium Brazil Canada Czech Republic Finland France Germany Greece Hungary Ireland Italy Mexico Netherlands Norway Poland South Africa Spain Sweden Switzerland United Kingdom,True,tacrolimus; ,,,699.0,3,True,True,False
NCT00224289,Effect of Age on Latanoprost 0.005% in Patients With Glaucoma,Completed,Interventional,2009-04-01,Yale University,Other,Pfizer,Industry,4,United States,True,Latanoprost 0.005%; ,,2012-11-09,17.0,4,True,False,False
NCT00237874,Aripiprazole Treatment of Prodromal Patients,Completed,Interventional,2007-02-01,Yale University,Other,Bristol-Myers Squibb,Industry,2/3,United States,True,Aripiprazole; ,,,15.0,2,True,True,False
NCT00243542,"Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency",Completed,Interventional,2006-10-01,Allergan,Industry,,,4,United States,True,"ACZONE Gel, 5%; Vehicle; ",,,64.0,4,True,False,True
NCT00243711,A Multi-Center Randomized Study to Evaluate the Efficacy and Safety of an Investigational Lubricant Eye Drop,Completed,Interventional,2006-04-01,Allergan,Industry,,,2/3,United States,True,Carboxymethylcellulose sodium and Glycerin; ,,,286.0,2,True,True,False
NCT00249782,"A Phase II, Randomized Study of ACZONE™ (Dapsone) Gel, 5% for Papulopustular Rosacea.",Completed,Interventional,2006-05-01,Allergan,Industry,,,2,United States,True,"Vehicle control, 2x/day; ACZONE (dapsone) Gel, 5%, 2x/day; ACZONE (dapsone) Gel, 5%, 1x/day; MetroGel® (metronidazole gel), 1.0% 1x/day; ACZONE (dapsone) Gel, 5%, 1x/day (AM) + MetroGel (metronidazole gel), 1.0%, 1x/day (PM); ",,,400.0,2,True,True,False
NCT00272285,"A Study of Ramosetron Plus DX, Dexamethasone, Compared to Granisetron Plus DX for the Prevention of Vomiting and Nausea",Completed,Interventional,2007-12-01,Astellas Pharma Inc,Industry,"Astellas Pharma Taiwan, Inc.",Industry,3,Taiwan,True,Ramosetron; Granisetron; ,,,287.0,3,True,True,False
NCT00281554,Study of RSD1235 to Evaluate Safety in Patients With Atrial Fibrillation,Completed,Interventional,2007-01-01,Astellas Pharma Inc,Industry,Cardiome Pharma,Industry,3,Argentina Canada Denmark South Africa Sweden United States,True,RSD1235; ,,,254.0,3,True,False,True
NCT00282243,A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients,Completed,Interventional,2008-10-01,Astellas Pharma Inc,Industry,,,2,United States,True,tacrolimus modified release (MR); tacrolimus; ,,2013-08-01,70.0,2,True,False,False
NCT00282256,A Study of a Modified-Release Tacrolimus Based Immunosuppression Regimen in Stable Pediatric Liver Transplant Patients,Completed,Interventional,2008-10-01,Astellas Pharma Inc,Industry,,,2,United States,True,tacrolimus modified release (MR); tacrolimus; ,,2013-08-12,19.0,2,True,False,False
NCT00282568,A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients,Completed,Interventional,2008-10-01,Astellas Pharma Inc,Industry,,,2,Canada United States,True,Tacrolimus Modified Release (MR); tacrolimus; ,,2013-07-25,70.0,2,True,False,False
NCT00283946,"A Double-blind, Group-comparison Study Using Zolpidem (Myslee) as a Comparative Drug in Patients With Insomnia",Completed,Interventional,2007-11-01,Astellas Pharma Inc,Industry,,,3,Japan,True,Zolpidem MR; Zolpidem; ,,,876.0,3,True,True,False
NCT00284518,Safety and Efficacy Study of Botulinum Toxin Type A to Treat Lower Urinary Symptoms Due to Benign Prostatic Hyperplasia,Completed,Interventional,2009-05-01,Allergan,Industry,,,2,"Australia Austria Canada Czech Republic France Germany Italy Korea, Republic of Slovakia Taiwan United Kingdom",True,normal saline; ,,2012-11-16,380.0,2,True,False,False
NCT00291213,Levetiracetam Treatment of Tardive Dyskinesia,Completed,Interventional,2006-04-01,Yale University,Other,UCB Pharma,Industry,3,United States,True,levetiracetam; placebo; ,,,50.0,3,True,False,True
NCT00291226,Glycine vs Placebo for the Schizophrenia Prodrome,Completed,Interventional,2009-07-01,Yale University,Other,"Glytech, Inc National Alliance for Research on Schizophrenia and Depression",Industry Other,2/3,United States,True,Glycine; Placebo; ,,,8.0,2,True,False,True
NCT00293917,A Study to Assess the Long-Term Safety of Tacrolimus Cream in the Treatment of Psoriasis,Completed,Interventional,2007-08-01,Astellas Pharma Inc,Industry,"Astellas Pharma US, Inc.",Industry,3,Canada United States,True,Tacrolimus Cream; ,,,658.0,3,True,True,False
NCT00295594,Comparing Efficacy & Safety of Tacrolimus With/Without MMF or Monoclonal Anti-IL2R Antibody in Liver Transplantation.,Completed,Interventional,2007-06-01,Astellas Pharma Inc,Industry,,,3,Belgium Denmark Finland Germany Hungary Italy Poland Spain Sweden Switzerland United Kingdom,True,tacrolimus; ,,,627.0,3,True,True,False
NCT00295607,Comparing Efficacy and Safety of Tacrolimus With Steroids or Monoclonal Anti-IL2R Antibody in Hepatitis C Virus (HCV) Positive Liver Transplant Patients,Completed,Interventional,2008-06-01,Astellas Pharma Inc,Industry,,,2,Czech Republic France Germany Italy Poland Spain Sweden United Kingdom,True,"Tacrolimus; steroids, monoclonal anti-IL2R antibody; ",,,138.0,2,True,True,False
NCT00296309,Comparing Efficacy & Safety of Tacrolimus & MMF With/Without Induction in the Elderly Following Kidney Transplantation.,Completed,Interventional,2006-08-01,Astellas Pharma Inc,Industry,Astellas Pharma Europe B.V.,Industry,3,Belgium France Germany Netherlands Spain Switzerland United Kingdom,True,Tacrolimus; ,,,267.0,3,True,True,False
NCT00296348,Comparing Efficacy and Safety of Steroid Withdrawal With Tacrolimus and MMF With Induction in Children After Kidney Transplantation,Completed,Interventional,2008-02-01,Astellas Pharma Inc,Industry,,,3,Belgium Czech Republic France Germany Hungary Israel Italy Poland Romania South Africa Sweden Taiwan Turkey United Kingdom,True,tacrolimus; mycophenolate mofetil; daclizumab; steroids; ,,,198.0,3,True,True,False
NCT00296361,To Compare the Efficacy and Safety of a Therapy of Tacrolimus With Sirolimus or MMF in Kidney Transplantation.,Completed,Interventional,2006-07-01,Astellas Pharma Inc,Industry,,,3,Australia Austria Belgium Czech Republic France Germany Hungary Italy Netherlands Poland Romania Spain Sweden United Kingdom,True,Tacrolimus; ,,,634.0,3,True,True,False
NCT00300443,Safety and Efficacy Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension,Completed,Interventional,2007-06-01,Allergan,Industry,,,2/3,United States,True,bimatoprost; ,,,561.0,2,True,False,True
NCT00309088,FK506 Phase 3 Study: a Study for Steroid Non-resistant Myasthenia Gravis (MG) Patients,Completed,Interventional,2008-06-01,Astellas Pharma Inc,Industry,,,3,Japan,True,tacrolimus; placebo; ,,,80.0,3,True,False,True
NCT00309101,"An Open Study for Steroid Resistant, Non-Thymectomized MG Patients",Completed,Interventional,2009-02-01,Astellas Pharma Inc,Industry,,,3,Japan,True,tacrolimus; ,,,11.0,3,True,True,False
NCT00309452,Specialized Treatment Early in Psychosis (STEP),Completed,Interventional,2013-08-01,Yale University,Other,,,,United States,True,Medications; ,,,120.0,5,True,False,True
NCT00319917,A Double Blind Placebo Controlled Study to Assess the Efficacy on Joint Damage in RA Patients,Completed,Interventional,2008-10-01,Astellas Pharma Inc,Industry,,,4,Japan,True,tacrolimus; placebo; ,,,123.0,4,True,True,False
NCT00321074,Tacrolimus and Daclizumab Versus Tacrolimus and Steroids in Liver Recipients Receiving Sub-optimal Grafts,Completed,Interventional,2007-10-01,Astellas Pharma Inc,Industry,,,3,Italy,True,TACROLIMUS; ,,,101.0,3,True,True,False
NCT00321113,Comparison of Two Tacrolimus Based Immunosuppressive Regimens in Recipients Receiving Marginal Donor Kidneys,Completed,Interventional,2008-03-01,Astellas Pharma Inc,Industry,,,3,Italy,True,tacrolimus; mycophenolate mofetil; steroids; ,,,142.0,3,True,True,False
NCT00328588,LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy,Completed,Interventional,2007-03-01,Astellas Pharma Inc,Industry,,,2,Czech Republic Germany Netherlands,True,YM155; ,,,37.0,2,True,True,False
NCT00333112,A Study to Evaluate Solifenacin Succinate in Combination With Tamsulosin for the Treatment of Residual Overactive Bladder Symptoms (OAB) in Men.,Completed,Interventional,2007-01-01,Astellas Pharma Inc,Industry,,,4,United States,True,solifenacin succinate; tamsulosin; placebo; ,,,398.0,4,True,True,False
NCT00333814,A Study of the Safety and Efficacy of a New Treatment for Non-Infectious Intermediate or Posterior Uveitis,Completed,Interventional,2008-12-01,Allergan,Industry,,,2/3,"Australia Austria Brazil Canada Czech Republic France Germany Greece India Israel Korea, Republic of Poland Portugal South Africa Spain Switzerland United Kingdom United States",True,Dexamethasone; dexamethasone; Sham injection; ,,2010-10-12,229.0,2,True,False,False
NCT00337090,A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON),Completed,Interventional,2007-03-01,Astellas Pharma Inc,Industry,Astellas Pharma Europe B.V.,Industry,2,Belgium Czech Republic Denmark France Germany Greece Hungary Italy Netherlands Norway Poland Russian Federation Spain Sweden United Kingdom,True,YM178; ,,,1108.0,2,True,True,False
NCT00337558,A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR),Completed,Interventional,2007-05-01,Astellas Pharma Inc,Industry,Astellas Pharma Europe B.V.,Industry,4,Australia Belgium Czech Republic France Hungary Italy Netherlands Poland Russian Federation Spain Turkey,True,Solifenacin succinate; ,,,643.0,4,True,True,False
NCT00337987,A Pilot Study to Determine the Safety of the Combination of Ontak in Combination With CHOP in Peripheral T-Cell Lymphoma,Completed,Interventional,2007-12-01,Yale University,Other,Eisai Inc.,Industry,2,United States,True,"Ontak; CHOP (cyclophosphamide (C), adriamycin (H), vincristine (O), and prednisone (P)) chemotherapy; ",,2015-01-28,49.0,2,True,False,False
NCT00347048,Tacrolimus (FK506) Study in Moderate to Severe Refractory Ulcerative Colitis Patients,Completed,Interventional,2008-04-01,Astellas Pharma Inc,Industry,,,3,Japan,True,tacrolimus; Placebo; ,,,62.0,3,True,True,False
NCT00353678,Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2),Completed,Interventional,2007-08-01,Astellas Pharma Inc,Industry,Astellas Pharma Europe B.V.,Industry,2,Austria Bosnia and Herzegovina Czech Republic Denmark Finland Germany Greece Italy Latvia Lithuania Norway Poland Russian Federation Serbia Slovakia Spain Sweden,True,YM150; ,,,1141.0,2,True,False,True
NCT00367991,Effects of Recombinant Human Erythropoietin on Platelet Function in Patients With Acute Myocardial Infarction,Completed,Interventional,2008-03-01,Yale University,Other,American Heart Association,Other,2,United States,True,Recombinant human erythropoietin alfa (drug); Placebo; ,,2011-08-09,44.0,2,True,False,False
NCT00368706,"A Double-Blind, Paralleled Study Comparing Efficacy/Safety of Solifenacin to Tolterodine in Overactive Bladder Patients",Completed,Interventional,2008-03-01,Astellas Pharma Inc,Industry,,,3,China,True,solifenacin succinate; tolterodine; ,,,246.0,3,True,True,False
NCT00374244,Efficacy of Pimozide Augmentation for Clozapine Partial Response,Completed,Interventional,2011-06-01,Yale University,Other,Stanley Medical Research Institute,Other,2,United States,True,Pimozide; placebo; ,,2013-01-10,28.0,2,True,False,False
NCT00374777,"A Double-blind, Group-comparison P-III Study With Zolpidem MR Using Placebo and Nitrazepam in Insomnia Patients",Completed,Interventional,2008-05-01,Astellas Pharma Inc,Industry,,,3,Japan,True,zolpidem MR; nitrazepam; placebo; ,,,450.0,3,True,True,False
NCT00378508,Anti-CD3 mAb Treatment of Recent Onset Type 1 Diabetes,Completed,Interventional,2011-08-01,Yale University,Other,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Juvenile Diabetes Research Foundation,NIH Other,2,United States,True,"mAb hOKT3gamma1(Ala-Ala), Teplizumab; Placebo Arm; ",,2012-09-04,63.0,2,True,False,False
NCT00378690,A Phase IIIb Study of Intermittent Versus Continuous Hormone Deprivation Treatment With ELIGARD,Completed,Interventional,2011-06-01,Astellas Pharma Inc,Industry,,,3,Belgium Czech Republic Finland France Germany Hungary Italy Russian Federation Slovakia Spain,True,leuprorelin acetate; ,,,706.0,3,True,False,True
NCT00379067,A Phase 4 Study With Tamsulosin OCAS to Assess Nighttime Voiding.,Completed,Interventional,2006-11-01,Astellas Pharma Inc,Industry,Astellas Pharma Europe Ltd. Boehringer Ingelheim,Industry Industry,4,,True,Tamsulosin OCAS; Placebo; ,,,882.0,4,True,True,False
NCT00381719,Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy,Completed,Interventional,2007-11-01,Allergan,Industry,,,2,United States,True,AGN 203818; AGN 203818; AGN 203818; placebo capsule; ,,,330.0,2,True,True,False
NCT00384137,A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Kidney Recipients,Completed,Interventional,2007-07-01,Astellas Pharma Inc,Industry,,,3,France Germany Netherlands Poland Spain United Kingdom,True,Tacrolimus; ,,,128.0,3,True,True,False
NCT00384202,A Conversion Study to Assess Safety and Efficacy of a MR4 Based Immunosuppressive Regimen in Stable Liver Recipients,Completed,Interventional,2007-11-01,Astellas Pharma Inc,Industry,,,3,France Germany Ireland Poland Spain United Kingdom,True,Tacrolimus; ,,,112.0,3,True,True,False
NCT00402714,"A Trial of Extracorporeal Photopheresis, Pentostatin, and Total Body Irradiation in Patients Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation for the Treatment of Malignancies",Completed,Interventional,2009-07-01,Yale University,Other,"Hospira, Inc.",Industry,2,United States,True,Pentostatin; Pentostatin; ,,,19.0,2,True,True,False
NCT00408239,Factor Xa Inhibitor for Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement,Completed,Interventional,2009-03-01,Astellas Pharma Inc,Industry,,,2,"Indonesia Japan Korea, Republic of Malaysia Philippines Singapore Taiwan Thailand",True,YM150; enoxaparin; ,,,367.0,2,True,True,False
NCT00410514,A Study of Mirabegron (YM178) in Men With Lower Urinary Tract Symptoms (LUTS) and Bladder Outlet Obstruction (BOO),Completed,Interventional,2008-08-01,Astellas Pharma Inc,Industry,,,2,Canada United States,True,Mirabegron; Placebo; ,,2012-08-02,200.0,2,True,False,False
NCT00411788,A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer,Completed,Interventional,2010-05-01,Yale University,Other,"Genentech, Inc.",Industry,2,United States,True,Rapamycin; Trastuzumab; ,,2016-06-17,11.0,2,True,False,False
NCT00412893,Isavuconazole (BAL8557) for Primary Treatment of Invasive Aspergillosis,Completed,Interventional,2013-03-01,Astellas Pharma Inc,Industry,Basilea Pharmaceutica International Ltd,Industry,3,"Argentina Australia Belgium Brazil Canada Chile China Egypt France Germany Hungary India Israel Italy Korea, Republic of Malaysia Mexico Netherlands New Zealand Poland Russian Federation Spain Switzerland Thailand Turkey United States",True,Isavuconazole; Voriconazole; ,,2015-03-19,527.0,3,True,False,False
NCT00413335,Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth,Completed,Interventional,2008-09-01,Yale University,Other,,,,United States,True,Rosiglitazone; Placebo; ,,2012-11-07,21.0,5,True,False,False
NCT00413439,"Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing Chemotherapy",Completed,Interventional,2007-06-01,Astellas Pharma Inc,Industry,Basilea Pharmaceutica,Industry,2/3,Germany,True,Isavuconazole; ,,,18.0,2,True,False,True
NCT00414167,"Craving, Binge Eating and Obesity",Completed,Interventional,2011-03-01,Yale University,Other,,,2/3,United States,True,bupropion; ,,2012-10-22,61.0,2,True,False,False
NCT00417612,Effectiveness of Paricalcitol in Reducing Parathyroid Hormone (PTH) Levels in X-linked Hypophosphatemic Rickets,Completed,Interventional,2012-08-01,Yale University,Other,National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS),NIH,3,United States,True,Paricalcitol; ,,2014-08-02,33.0,3,True,False,False
NCT00431041,Study to Compare the Safety and Efficacy of Solifenacin With Oxybutynin for the Treatment of Overactive Bladder (VECTOR),Completed,Interventional,2008-02-01,Astellas Pharma Inc,Industry,"Astellas Pharma Canada, Inc.",Industry,4,Canada,True,solifenacin; oxybutynin immediate release; ,,2009-10-05,132.0,4,True,False,False
NCT00432198,Zolpidem Postmarketing Study in Adolescent Patients With Insomnia,Completed,Interventional,2010-01-01,Astellas Pharma Inc,Industry,,,4,Japan,True,Zolpidem (Myslee®); placebo; ,,,122.0,4,True,True,False
NCT00440011,Bimatoprost 0.03% Versus Travoprost 0.004% in Patients Currently on Latanoprost 0.005%,Completed,Interventional,2007-10-01,Allergan,Industry,,,4,United States,True,bimatoprost 0.03% eye drops; travoprost 0.004% eye drops; ,,2008-09-25,266.0,4,True,False,False
NCT00440141,Brimonidine 0.1% Versus Brinzolamide 1% as Adjunctive Therapy to Latanoprost 0.005%,Completed,Interventional,2007-03-01,Allergan,Industry,,,4,United States,True,latanoprost 0.005% eye drops and brimonidine 0.1% eye drops; latanoprost 0.005% eye drops and brinzolamide 1.0% eye drops; ,,,40.0,4,True,False,True
NCT00448214,Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation,Completed,Interventional,2008-10-01,Astellas Pharma Inc,Industry,,,2,"Australia Hong Kong Japan Korea, Republic of Malaysia New Zealand Singapore South Africa Taiwan Thailand",True,YM150; warfarin; ,,,448.0,2,True,True,False
NCT00454233,A Safety and Efficacy Study With YM543 in Type 2 Diabetes Mellitus Subjects,Completed,Interventional,2008-06-01,Astellas Pharma Inc,Industry,,,2,Russian Federation,True,YM543; Metformin; Placebo; ,,,97.0,2,True,True,False
NCT00457795,24-hour IOP-lowering Effect of Brimonidine 0.1%,Completed,Interventional,2009-02-01,Allergan,Industry,,,4,United States,True,brimonidine 0.1% (Alphagan® P); ,,2011-10-18,15.0,4,True,False,False
NCT00459719,A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Liver Transplantation,Completed,Interventional,2009-03-01,Astellas Pharma Inc,Industry,,,3,China,True,Tacrolimus modified-release; Prograf; ,,,42.0,3,True,True,False
NCT00461851,"Trial of Gemcitabine, Carboplatin, and Sorafenib in Chemotherapy-naive Patients With Advanced/Metastatic Bladder Carcinoma",Completed,Interventional,2013-08-01,Yale University,Other,Bayer,Industry,2,United States,True,Gemcitabine; Carboplatin; Sorafenib; ,,,30.0,2,True,True,False
NCT00464438,A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial Conjunctivitis,Completed,Interventional,2008-09-01,Allergan,Industry,,,4,Canada United States,True,gatifloxacin; moxifloxacin 0.5% eye drops; ,,2010-06-15,171.0,4,True,False,False
NCT00464685,Safety and Efficacy of a New Treatment in Combination With Laser for Diabetic Macular Edema,Completed,Interventional,2010-02-01,Allergan,Industry,,,2,Canada United States,True,Dexamethasone; Sham injection; ,,2014-07-10,253.0,2,True,False,False
NCT00481481,Conversion Study From Cyclosporine to FK506MR Based Immunosuppression in Kidney Transplant Subjects,Completed,Interventional,2009-04-01,Astellas Pharma Inc,Industry,,,3,Austria Belgium Czech Republic Denmark Finland France Germany Hungary Italy Poland Spain Sweden Switzerland,True,tacrolimus; ,,,346.0,3,True,False,True
NCT00481819,A Study to Compare the Efficacy and Safety of FK506MR vs Prograf® in Patients Undergoing Kidney Transplantation,Completed,Interventional,2009-03-01,Astellas Pharma Inc,Industry,,,3,China,True,FK506MR; Prograf; Mycophenolate Mofetil; Methylprednisolone; Prednisolone; ,,,240.0,3,True,True,False
NCT00486330,Pharmacokinetic Interactions Between Buprenorphine and Tipranavir/Ritonavir,Completed,Interventional,2007-05-01,Yale University,Other,Boehringer Ingelheim,Industry,,United States,True,"Buprenorphine, Tipranavir and ritonavir; ",,2010-02-25,12.0,5,True,False,False
NCT00487682,Dose-finding Study of ASP2151 in Subjects With Herpes Zoster,Completed,Interventional,2008-09-01,Astellas Pharma Inc,Industry,,,2,Japan,True,ASP2151; Valacyclovir hydrochloride; ,,,403.0,2,True,True,False
NCT00493324,Study to Evaluate the Immune Response to Pneumococcal Vaccine in Alefacept-treated Adults With Chronic Plaque Psoriasis,Completed,Interventional,2008-07-01,Astellas Pharma Inc,Industry,,,4,Canada United States,True,alefacept; polyvalent pneumococcal vaccine; ,,,43.0,4,True,True,False
NCT00505037,A Phase 2 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis,Completed,Interventional,2008-09-01,Astellas Pharma Inc,Industry,,,2,Japan,True,ASP1585; Placebo; Sevelamer hydrochloride; ,,,156.0,2,True,False,True
NCT00507455,Solifenacin Succinate With Tamsulosin HCl in Males With Lower Urinary Tract Symptoms and Bladder Outlet Obstruction,Completed,Interventional,2008-08-01,Astellas Pharma Inc,Industry,,,2,Belgium Czech Republic Germany Hungary Poland United States,True,solifenacin succinate; tamsulosin hydrochloride; Placebo to solifenacin; Placebo to tamsulosin; ,,2014-07-14,222.0,2,True,False,False
NCT00509873,A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis,Completed,Interventional,2008-06-01,Allergan,Industry,,,3,United States,True,Gatifloxacin 0.5% eye drops; placebo eye drops; ,,2010-06-15,578.0,3,True,False,False
NCT00510406,A Study With Combination Treatment (Tamsulosin Hydrochloride and Solifenacin Succinate) in Male Patients With LUTS/BPH,Completed,Interventional,2007-09-01,Astellas Pharma Inc,Industry,,,2,Austria Czech Republic Denmark Finland France Germany Hungary Netherlands Norway Poland Portugal Russian Federation Slovakia Spain Sweden United Kingdom,True,tamsulosin hydrochloride; solifenacin succinate; Placebo; ,,,919.0,2,True,False,True
NCT00511706,Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD),Completed,Interventional,2009-03-01,Allergan,Industry,,,2,"Australia France Israel Italy Korea, Republic of New Zealand Portugal United Kingdom United States",True,dexamethasone; ,,2012-08-01,243.0,2,True,False,False
NCT00514852,Safety and Efficacy of an Artificial Tear for the Treatment of Dry Eye,Completed,Interventional,2008-01-01,Allergan,Industry,,,,United States,True,Carboxymethylcellulose and Glycerin based artificial tear; Carboxymethylcellulose; ,,2009-05-19,316.0,5,True,False,False
NCT00516919,Study of Behavioral Weight Loss Therapy for Obesity and Binge Eating in Monolingual Hispanic Persons,Completed,Interventional,2010-12-01,Yale University,Other,Donaghue Medical Research Foundation,Other,4,United States,True,Xenical + behavioral intervention; ,,2012-07-31,79.0,4,True,False,False
NCT00518089,A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis,Completed,Interventional,2009-01-01,Allergan,Industry,,,3,India United States,True,Gatifloxacin 0.5% eye drops; placebo eye drops; ,,2010-06-15,859.0,3,True,False,False
NCT00521456,A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery,Completed,Interventional,2008-03-01,Allergan,Industry,,,3,United States,True,ketorolac eye drops; ,,2009-08-19,263.0,3,True,False,False
NCT00524264,A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery,Completed,Interventional,2008-04-01,Allergan,Industry,,,3,United States,True,ketorolac; ,,2009-08-19,248.0,3,True,False,False
NCT00527033,A Study of YM178 in Patients With Symptomatic Overactive Bladder,Completed,Interventional,2008-04-01,Astellas Pharma Inc,Industry,,,2,Japan,True,YM178; Placebo; ,,,842.0,2,True,False,True
NCT00530530,ASP8825 - Study in Patients With Restless Legs Syndrome,Completed,Interventional,2009-01-01,Astellas Pharma Inc,Industry,,,2,Japan,True,ASP8825; Placebo; ,,,474.0,2,True,False,True
NCT00536198,Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder,Completed,Interventional,2012-02-01,Yale University,Other,National Institute of Mental Health (NIMH),NIH,4,United States,True,Sertraline; Placebo; ,,2016-01-05,252.0,4,True,False,False
NCT00537810,Treatment of Binge Eating in Obese Patients in Primary Care,Completed,Interventional,2012-10-01,Yale University,Other,National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH NIH,4,United States,True,Sibutramine; Placebo; ,,2014-06-19,104.0,4,True,False,False
NCT00538304,A Study of the Safety and Efficacy of Bimatoprost in Patients With Glaucoma or Ocular Hypertension,Completed,Interventional,2008-05-01,Allergan,Industry,,,2,United States,True,bimatoprost eye drops; placebo; ,,2011-09-19,222.0,2,True,False,False
NCT00539526,Evaluation of Hyperemia With the Use of Ocular Prostaglandin Analogues,Completed,Interventional,2008-07-01,Allergan,Industry,,,4,United States,True,Bimatoprost 0.03%; travoprost 0.004%; latanoprost 0.005% eye drops; ,,2011-09-22,106.0,4,True,False,False
NCT00541242,Safety and Efficacy of Bimatoprost Compared With Latanoprost in Patients With Glaucoma or Ocular Hypertension,Completed,Interventional,2008-08-01,Allergan,Industry,,,4,United States,True,bimatoprost 0.03% eye drops; latanoprost 0.005% eye drops; ,,2011-09-19,586.0,4,True,False,False
NCT00543569,A Study to Assess the Safety and Efficacy of Alefacept in Kidney Transplant Recipients,Completed,Interventional,2011-02-01,Astellas Pharma Inc,Industry,,,2,United States,True,Alefacept; tacrolimus; basiliximab; mycophenolate mofetil; Corticosteroids; ,,2015-11-06,323.0,2,True,False,False
NCT00544713,Evaluate the Safety and Efficacy of a New Artificial Tear for Use After LASIK Surgery,Completed,Interventional,2008-06-01,Allergan,Industry,,,,United States,True,Carboxymethylcellulose and Glycerin based artificial tear; Carboxymethylcellulose; ,,2009-06-29,228.0,5,True,False,False
NCT00554970,A Study of 2 Doses of MAP0010 in Adult Asthmatics,Completed,Interventional,2008-01-01,Allergan,Industry,"MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan",Industry,2,United States,True,MAP0010 low dose; MAP0010 high dose; Budesonide inhalation suspension 0.25mg; Budesonide inhalation suspension 0.5mg; ,,2013-08-19,32.0,2,True,False,False
NCT00563797,Mecamylamine for the Treatment of Patients With Depression and Alcohol Dependence,Completed,Interventional,2014-07-01,Yale University,Other,National Alliance for Research on Schizophrenia and Depression,Other,3,United States,True,Mecamylamine; Placebo; ,,2015-11-16,21.0,3,True,False,False
NCT00564681,"Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia",Completed,Interventional,2008-12-01,Allergan,Industry,,,2,Canada Czech Republic Germany Hungary India Philippines Poland Russian Federation Serbia Singapore Slovakia South Africa Taiwan Thailand United Kingdom United States,True,Normal Saline; ,,2012-11-14,242.0,2,True,False,False
NCT00566150,Levetiracetam in the Management of Bipolar Depression,Completed,Interventional,2008-08-01,Yale University,Other,Stanley Medical Research Institute,Other,,United States,True,Levetiracetam; Placebo; ,,2009-10-02,35.0,5,True,False,False
NCT00566969,Cocaine Withdrawal and Pharmacotherapy Response,Completed,Interventional,2012-12-01,Yale University,Other,National Institute on Drug Abuse (NIDA),NIH,,United States,True,sugar pill; Carvedilol 25 mg; Carvedilol 50 mg; ,,2016-08-16,106.0,5,True,False,False
NCT00567320,Efficacy of Varenicline in Methadone-Stabilized Cocaine Users,Completed,Interventional,2009-06-01,Yale University,Other,National Institute on Drug Abuse (NIDA) VA Office of Research and Development,NIH U.S. Fed,,United States,True,Varenicline; Sugar pill or Placebo; ,,2012-02-08,31.0,5,True,False,False
NCT00567918,"Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis",Completed,Interventional,2008-01-01,Astellas Pharma Inc,Industry,,,3,Japan,True,FK506; ,,,52.0,3,True,True,False
NCT00568516,Phase II Study of ASP3550 in Patients With Prostate Cancer,Completed,Interventional,2009-10-01,Astellas Pharma Inc,Industry,,,2,Japan,True,ASP3550; ,,,273.0,2,True,True,False
NCT00568958,Naltrexone for Heavy Drinking in Young Adults,Completed,Interventional,2012-12-01,Yale University,Other,National Institute on Alcohol Abuse and Alcoholism (NIAAA),NIH,4,United States,True,naltrexone; placebo naltrexone; ,,2014-03-04,140.0,4,True,False,False
NCT00569192,A Study of 2 Doses of MAP0010 and Placebo in Asthmatic Children,Completed,Interventional,2008-09-01,Allergan,Industry,"MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan",Industry,3,,True,0.135mg MAP0010; 0.25mg MAP0010; Placebo; ,,2013-08-19,360.0,3,True,False,False
NCT00571961,Pharmacokinetic Interactions Between Buprenorphine and Kaletra (Lopinavir/Ritonavir),Completed,Interventional,2008-08-01,Yale University,Other,Abbott,Industry,,United States,True,Kaletra (lopinavir/ritonavir); buprenorphine; ,,2012-05-25,12.0,5,True,False,False
NCT00573508,Study of VESIcare® In Overactive Bladder (OAB) Subjects to Evaluate Symptom Bother and Health Related Quality of Life,Completed,Interventional,2008-07-01,Astellas Pharma Inc,Industry,,,4,United States,True,Placebo; Solifenacin Succinate; ,,2010-02-02,768.0,4,True,False,False
NCT00582491,"Modafinil, Sleep, and Cognition in Cocaine Dependence",Completed,Interventional,2009-02-01,Yale University,Other,National Institute on Drug Abuse (NIDA),NIH,,United States,True,Modafinil; Placebo; ,,2012-08-06,44.0,5,True,False,False
NCT00585169,Memantine Treatment Study of Pathological Gambling,Completed,Interventional,2011-12-01,Yale University,Other,University of Minnesota - Clinical and Translational Science Institute Forest Laboratories,Other Industry,2,United States,True,Memantine Hydrochloride; ,,2013-01-29,29.0,2,True,False,False
NCT00588731,Cannabidiol Treatment of Cognitive Dysfunction in Schizophrenia,Completed,Interventional,2013-12-01,Yale University,Other,Stanley Medical Research Institute,Other,2,United States,True,Cannabidiol; Placebo; ,,,36.0,2,True,True,False
NCT00593125,Levetiracetam (Keppra) Tolerability in Cocaine Abusing Methadone-maintained Patients.,Completed,Interventional,2007-08-01,Yale University,Other,,,2,United States,True,levetiracetam; ,,,15.0,2,True,True,False
NCT00606801,Galantamine Effects on Cognitive Function in Abstinent Cocaine Users,Completed,Interventional,2009-02-01,Yale University,Other,National Institute on Drug Abuse (NIDA),NIH,,United States,True,Galantamine; placebo; ,,2012-02-08,34.0,5,True,False,False
NCT00606892,Varenicline and Nicotine Interactions in Humans (VA),Completed,Interventional,2008-11-01,Yale University,Other,VA Office of Research and Development National Institute on Drug Abuse (NIDA),U.S. Fed NIH,,United States,True,Varenicline; Placebo; IV Nic; ,,2012-03-14,37.0,5,True,False,False
NCT00611403,Safety and Efficacy Study of Cyclosporine Ophthalmic Emulsion in Post-LASIK Patients,Completed,Interventional,2008-12-01,Allergan,Industry,,,2,United States,True,Cyclosporine Ophthalmic Emulsion 0.05% (RESTASIS®); Artificial Tears REFRESH ENDURA®; ,,2011-11-17,137.0,2,True,False,False
NCT00611533,Placebo Controlled Study of Atomoxetine in the Treatment of Mild to Moderate Cognitive Difficulties in Menopausal Women,Completed,Interventional,2008-04-01,Yale University,Other,Eli Lilly and Company,Industry,,United States,True,atomoxetine; placebo; ,,,16.0,5,True,True,False
NCT00611767,GABA Mechanisms Underlying the Vulnerability to Alcohol Dependence,Completed,Interventional,2012-04-01,Yale University,Other,,,,United States,True,Thiopental; Placebo; ,,,2.0,5,True,True,False
NCT00617604,A Study to Assess the Efficacy and Safety of Alefacept in Kidney Transplant Recipients,Completed,Interventional,2009-09-01,Astellas Pharma Inc,Industry,,,2,Austria Belgium Czech Republic France Germany Hungary Italy Netherlands Poland Spain Sweden United Kingdom,True,Alefacept; placebo; Tacrolimus; Mycophenolate Mofetil; Steroids; ,,2016-01-05,218.0,2,True,False,False
NCT00619398,A Study to Evaluate and Compare the Efficacy and Safety of FK506MR vs Prograf® in Stable Liver Transplantation Patients,Completed,Interventional,2009-03-01,Astellas Pharma Inc,Industry,,,3,China,True,Prograf; FK506MR capsule; ,,,172.0,3,True,True,False
NCT00621868,A Phase 2 Study of ASP1941 in Japanese Patients With Type 2 Diabetes Mellitus,Completed,Interventional,2009-03-01,Astellas Pharma Inc,Industry,,,2,Japan,True,ASP1941; Placebo; ,,,361.0,2,True,False,True
NCT00623636,Phase 3 Study of MAP0004 in Adult Migraineurs,Completed,Interventional,2010-12-01,Allergan,Industry,"MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan",Industry,3,United States,True,MAP0004; Placebo; ,,2013-08-19,902.0,3,True,False,False
NCT00626340,Brain Imaging Study in Menopausal Women With and Without Major Depressive Disorder,Completed,Interventional,2008-06-01,Yale University,Other,,,4,United States,True,estrogen alone; fluoxetine alone; estrogen and fluoxetine together; ,,,18.0,4,True,True,False
NCT00629642,Clinical Study of Solifenacin Succinate in Patients With Bladder Symptoms Due to Spinal Cord Injury or Multiple Sclerosis,Completed,Interventional,2011-01-01,Astellas Pharma Inc,Industry,,,4,Australia Belgium Czech Republic France Germany Hungary Italy Netherlands Russian Federation Spain United Kingdom,True,Solifenacin Succinate; Solifenacin Succinate; Oxybutynin Hydrochloride; Placebo; ,,,249.0,4,True,True,False
NCT00630955,Family History Study of Alcohol Consumption Using Memantine,Completed,Interventional,2011-05-01,Yale University,Other,National Institute on Alcohol Abuse and Alcoholism (NIAAA),NIH,2,United States,True,memantine; Memantine; Placebo; ,,2013-08-19,111.0,2,True,False,False
NCT00633256,The Effect of Cycloserine on Smoking Behavior in Nicotine Dependent Smokers,Completed,Interventional,2008-02-01,Yale University,Other,VA Connecticut Healthcare System,U.S. Fed,,United States,True,Cycloserine; Placebo; ,,2012-03-14,20.0,5,True,False,False
NCT00634049,Isavuconazole in the Treatment of Renally Impaired Aspergillosis and Rare Fungi,Completed,Interventional,2014-01-01,Astellas Pharma Inc,Industry,Basilea Pharmaceutica International Ltd,Industry,3,"Argentina Australia Belgium Brazil Canada Chile Egypt France Germany India Israel Korea, Republic of Lebanon Mexico Poland Russian Federation South Africa Thailand United States",True,isavuconazole; ,,2015-12-02,149.0,3,True,False,False
NCT00635102,Glycine and Oral D-Cycloserine in Alcoholic Patients and Healthy Subjects,Completed,Interventional,2008-02-01,Yale University,Other,,,,,True,D-Cycloserine PO and Glycine IV; Placebo; ,,,40.0,5,True,True,False
NCT00635700,Ziprasidone in the Psychosis Prodrome,Completed,Interventional,2012-11-01,Yale University,Other,,,2,Canada United States,True,ziprasidone; placebo; ,,,66.0,2,True,True,False
NCT00637143,Tacrolimus as Secondary Intervention vs. Continuation of Cyclosporine in Renal Transplant Patients With Chronic Renal Allograft Failure (CRAF),Completed,Interventional,2006-02-01,Astellas Pharma Inc,Industry,"Astellas Pharma Canada, Inc.",Industry,4,Canada,True,Tacrolimus; Cyclosporine; ,,,107.0,4,True,True,False
NCT00643071,"Tacrolimus (FK506) P-III, Open-label Study in Refractory Ulcerative Colitis Patients",Completed,Interventional,2008-05-01,Astellas Pharma Inc,Industry,,,3,Japan,True,Tacrolimus; ,,,32.0,3,True,True,False
NCT00645944,"Randomized, Controlled, Double Blind Trial of Eszopiclone for Insomnia Associated With Schizophrenia",Completed,Interventional,2011-04-01,Yale University,Other,Sunovion,Industry,,United States,True,Eszopiclone; Placebo; ,,2015-05-05,39.0,5,True,False,False
NCT00650468,A Study to Compare Early Steroid Withdrawal and Long-Term Steroid Maintenance Therapy in Kidney Transplant Patients,Completed,Interventional,2007-12-01,Astellas Pharma Inc,Industry,,,4,United States,True,tacrolimus; CellCept; steroids (methylprednisone or prednisone); ,,,397.0,4,True,False,True
NCT00651612,Study to Evaluate Safety of Brimonidine/Timolol Fixed Combination in Glaucoma or Ocular Hypertension Patients,Completed,Interventional,2007-01-01,Allergan,Industry,,,3,United States,True,Brimonidine 0.2%/Timolol 0.5% Fixed Combination Ophthalmic Solution; Concurrent brimonidine 0.2% and 0.5% timolol; ,,,604.0,3,True,True,False
NCT00653562,Zolpidem (Myslee) Post Marketing Study in Adolescent Patients With Insomnia - Evaluation With Polysomnography,Completed,Interventional,2010-03-01,Astellas Pharma Inc,Industry,,,4,Japan,True,zolpidem; ,,,11.0,4,True,True,False
NCT00658606,Assess the Efficacy and Safety of Alefacept With Narrow Band Ultraviolet B Phototherapy (nbUVB) vs. Alefacept Alone in Chronic Plaque Psoriasis Subjects,Completed,Interventional,2009-12-01,Astellas Pharma Inc,Industry,"Astellas Pharma Canada, Inc.",Industry,4,Canada,True,alefacept; ,,2011-02-17,98.0,4,True,False,False
NCT00658619,Safety and Efficacy of Brimonidine Intravitreal Implant in Patients With Geographic Atrophy Due to Age-related Macular Degeneration (AMD),Completed,Interventional,2010-06-01,Allergan,Industry,,,2,"Australia Germany Italy Korea, Republic of Philippines Portugal United States",True,400 µg Brimonidine Tartrate Implant; 200 µg Brimonidine Tartrate Implant; ,,2013-03-13,119.0,2,True,False,False
NCT00660192,Investigation of Efficacy and Safety of Botulinum Toxin A (Botox-Allergan Inc) in Migraine Headaches,Completed,Interventional,2012-07-01,Yale University,Other,,,2/3,United States,True,Botox; ,,2014-08-18,25.0,2,True,False,False
NCT00662909,Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder,Completed,Interventional,2009-04-01,Astellas Pharma Inc,Industry,,,3,Canada United States,True,Mirabegron; Placebo; ,,2012-07-11,2149.0,3,True,False,False
NCT00667498,Metabolic Effect of Metformin in Obese Insulin Resistant Adolescents With Normal Glucose Tolerance,Completed,Interventional,2007-12-01,Yale University,Other,National Institutes of Health (NIH),NIH,4,United States,True,Metformin; Placebo; ,,,28.0,4,True,True,False
NCT00668070,A Proof-of-principle Study of Oral Treatment of Non-alcoholic Steatohepatitis With a Novel PDE4 Inhibitor ASP9831,Completed,Interventional,2010-10-01,Astellas Pharma Inc,Industry,,,2,Belgium Czech Republic France Germany Romania Switzerland United Kingdom,True,ASP9831; Placebo; ,,,114.0,2,True,True,False
NCT00673673,FOLFOX With Bevacizumab in Metastatic or Unresectable Gastroesophageal and Gastric Cancer,Completed,Interventional,2013-05-01,Yale University,Other,"Genentech, Inc.",Industry,2,United States,True,FOLFOX; bevacizumab; ,,2014-05-13,39.0,2,True,False,False
NCT00676026,Impact of GABA-Enhancing Agents on Cortical GABA Concentrations Across the Menstrual Cycle in Women,Completed,Interventional,2009-02-01,Yale University,Other,,,,United States,True,Fluoxetine; Zolpidem; Progesterone; ,,,8.0,5,True,True,False
NCT00678574,The Role of GABA and Neurosteroids in Premenstrual Dysphoric Disorder,Completed,Interventional,2008-12-01,Yale University,Other,National Institute of Mental Health (NIMH),NIH,4,United States,True,fluoxetine; ,,,20.0,4,True,True,False
NCT00688688,Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder,Completed,Interventional,2010-05-01,Astellas Pharma Inc,Industry,,,3,Australia Austria Belarus Belgium Canada Czech Republic Denmark Finland France Germany Hungary Iceland Ireland Italy Latvia Lithuania Netherlands Norway Poland Portugal Romania Russian Federation Slovakia South Africa Spain Sweden Switzerland Ukraine United Kingdom United States,True,Mirabegron; Tolterodine; Placebo to Mirabegron; Placebo to Tolterodine; ,,2012-07-23,2792.0,3,True,False,False
NCT00689104,Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder,Completed,Interventional,2009-03-01,Astellas Pharma Inc,Industry,,,3,Australia Austria Belarus Belgium Bulgaria Czech Republic Denmark Finland France Germany Greece Hungary Iceland Ireland Italy Latvia Lithuania Netherlands Norway Poland Portugal Romania Russian Federation Slovakia South Africa Spain Sweden Switzerland Ukraine United Kingdom,True,Mirabegron; Tolterodine; Placebo to Mirabegron; Placebo to Tolterodine; ,,2012-07-17,2336.0,3,True,False,False
NCT00693420,Safety and Efficacy of Bimatoprost Solution in Increasing Overall Eyelash Prominence,Completed,Interventional,2007-10-01,Allergan,Industry,,,3,Canada United States,True,Bimatoprost 0.03% sterile solution; vehicle sterile solution; ,,2009-01-14,278.0,3,True,False,False
NCT00693485,Safety and Effects of Brimonidine Intravitreal Implant in Patients With Glaucomatous Optic Neuropathy,Completed,Interventional,2011-01-01,Allergan,Industry,,,2,Israel United States,True,400 ug Brimonidine Implant; 200 ug Brimonidine Implant; Sham (no implant); ,,2013-03-13,70.0,2,True,False,False
NCT00697801,Study of MAP0010 in Asthmatic Children and Adolescents,Completed,Interventional,2006-12-01,Allergan,Industry,"MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan",Industry,2,United States,True,MAP0010 low dose; MAP0010 high dose; Placebo; ,,2013-08-19,208.0,2,True,False,False
NCT00717379,Study of Tacrolimus Immunosuppressive Therapy After Kidney Transplantation,Completed,Interventional,2008-10-01,Astellas Pharma Inc,Industry,,,4,Russian Federation,True,Tacrolimus; Mycophenolate Mofetil; Methylprednisolone or equivalent; Prednisone; ,,,50.0,4,True,True,False
NCT00717470,A Study in Kidney Transplant Subjects to Investigate the Optimal Suppression of Immunity to Help Prevent Kidney Rejection,Completed,Interventional,2010-03-01,Astellas Pharma Inc,Industry,,,4,Argentina Austria Belgium Czech Republic France Germany Greece Hungary Ireland Italy Netherlands Norway Poland Portugal Romania Russian Federation Slovakia South Africa Spain Sweden Switzerland United Kingdom,True,Prograf®; Advagraf®; Mycophenolate Mofetil; Simulect; methylprednisolone / prednisone; ,,,1252.0,4,True,False,True
NCT00717678,A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Kidney Transplant Recipients,Completed,Interventional,2010-04-01,Astellas Pharma Inc,Industry,"Astellas Pharma Taiwan, Inc.",Industry,3,Taiwan,True,Prograf-XL; Prograf; MMF; ,,,73.0,3,True,True,False
NCT00719160,The Effect of Protein on Calcium Absorption and Gastric Acid Production,Completed,Interventional,2008-05-01,Yale University,Other,,,4,United States,True,esomeprazole; Placebo; ,,2012-01-26,12.0,4,True,False,False
NCT00719186,Pregnancy in Polycystic Ovary Syndrome II,Completed,Interventional,2013-05-01,Yale University,Other,"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Penn State University University of Colorado, Denver University of Michigan University of Pennsylvania The University of Texas Health Science Center at San Antonio University of Vermont Wayne State University",NIH Other Other Other Other Other Other Other,3,United States,True,Clomiphene citrate; Letrozole; ,,2014-03-25,750.0,3,True,False,False
NCT00719745,A Study to Assess the Safety and Efficacy of Prograf and MR4 in Liver Transplant Recipients,Completed,Interventional,2008-06-01,Astellas Pharma Inc,Industry,"Astellas Pharma Korea, Inc.",Industry,3,"Korea, Republic of",True,Prograf; MR4; ,,,74.0,3,True,True,False
NCT00720265,A Study to Assess the Safety and Efficacy of Prograf and MR4 in Kidney Transplantation Patients,Completed,Interventional,2008-03-01,Astellas Pharma Inc,Industry,"Astellas Pharma Korea, Inc.",Industry,3,"Korea, Republic of",True,Prograf; MR4; ,,,135.0,3,True,True,False
NCT00720408,A Randomized Study to Assess the Safety and Efficacy of Prograf vs Prograf-XL in de Novo Liver Transplant Recipients.,Completed,Interventional,2009-09-01,Astellas Pharma Inc,Industry,"Astellas Pharma Taiwan, Inc.",Industry,3,Taiwan,True,Prograf-XL; Prograf; MMF; ,,,48.0,3,True,True,False
NCT00735449,Comparing Efficacy and Safety of Combigan With Timolol Adjunctive to Xalatan in Glaucoma or Ocular Hypertension Subjects,Completed,Interventional,2009-12-01,Allergan,Industry,,,4,Canada United States,True,Fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5%; timolol maleate 0.5%; latanoprost 0.005%; ,,2011-10-17,204.0,4,True,False,False
NCT00743574,Health Benefits of Vitamin D and Calcium in Women With PCOS (Polycystic Ovarian Syndrome),Completed,Interventional,2013-02-01,Yale University,Other,National Center for Research Resources (NCRR),NIH,,United States,True,Medroxyprogesterone (Provera); ,,2013-02-15,36.0,5,True,False,False
NCT00744055,Prazosin for Treatment of Patients With Alcohol Dependence (AD) and Post Traumatic Stress Disorder (PTSD).,Completed,Interventional,2014-10-01,Yale University,Other,,,3,United States,True,Prazosin; Placebo; ,,2015-10-27,96.0,3,True,False,False
NCT00756678,Efficacy and Acceptability of Two Lubricant Eye Drops,Completed,Interventional,2009-08-01,Allergan,Industry,,,4,United States,True,Lubricant Eye Drops (Optive™); Lubricating Eye Drops (blink® Tears); ,,2011-09-22,51.0,4,True,False,False
NCT00761202,Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms,Completed,Interventional,2008-06-01,Allergan,Industry,,,4,United Kingdom,True,"A sterile solution containing sodium carboxymethylcellulose and glycerin, preserved with PURITE®; Sodium hyaluronate; ",,2010-01-12,50.0,4,True,False,False
NCT00764374,"A Long-term, Open-label, Uncontrolled Trial of YM443 (Z-338) in Patients With Functional Dyspepsia",Completed,Interventional,2009-12-01,Astellas Pharma Inc,Industry,,,3,Japan,True,YM443; ,,,412.0,3,True,True,False
NCT00771394,Solifenacin as Add-on Therapy for Overactive Bladder Symptoms in Men Treated for Benign Prostatic Hyperplasia,Completed,Interventional,2010-01-01,Astellas Pharma Inc,Industry,,,4,Japan,True,Tamsulosin hydrochloride; Solifenacin succinate; ,,,638.0,4,True,True,False
NCT00775411,Safety and Efficacy of a New Therapy as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) in Subjects With Wet Age-Related Macular Degeneration (AMD),Completed,Interventional,2009-11-01,Allergan,Industry,,,2,Australia Philippines United States,True,dexamethasone; ,,2012-08-01,44.0,2,True,False,False
NCT00791323,Efficacy of Ketorolac 0.4% in Prostaglandin Suppression,Completed,Interventional,2009-08-01,Allergan,Industry,,,4,United States,True,Ketorolac 0.4%; Lubricating Eye Drop; ,,2011-08-17,9.0,4,True,False,False
NCT00793780,Pilot Trial of Naltrexone for Obesity in Women With Schizophrenia,Completed,Interventional,2010-11-01,Yale University,Other,Ethel F. Donaghue Women's Health Investigator Program at Yale,Other,,United States,True,Naltrexone 25mg; ,,2016-06-28,24.0,5,True,False,False
NCT00794443,ONO-5920/YM529 Confirmatory Study in Involutional Osteoporosis Patients,Completed,Interventional,2010-04-01,Astellas Pharma Inc,Industry,Ono Pharmaceutical Co. Ltd,Industry,2/3,Japan,True,YM529 / ONO-5920; ,,,692.0,2,True,True,False
NCT00794703,A Study to Compare Efficacy and Safety of Mycamine® and Itraconazole for Preventing Fungal Infections,Completed,Interventional,2009-11-01,Astellas Pharma Inc,Industry,,,3,China,True,micafungin (Mycamine); itraconazole; ,,,288.0,3,True,False,True
NCT00799227,Safety and Efficacy of a New Treatment in Vitrectomized Subjects With Diabetic Macular Edema,Completed,Interventional,2009-12-01,Allergan,Industry,,,2,Australia United States,True,Dexamethasone; ,,2014-07-10,56.0,2,True,False,False
NCT00811564,An Evaluation of the Fixed Combination Brimonidine Tartrate 0.2%/ Timolol Maleate 0.5% to Latanoprost 0.005% in Glaucoma or Ocular Hypertension Subjects,Completed,Interventional,2010-01-01,Allergan,Industry,,,4,United States,True,fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution; latanoprost 0.005%; ,,2011-08-17,148.0,4,True,False,False
NCT00811850,Comparing Effects of Two Fixed Combinations Ophthalmic Solutions on Ocular Blood Flow,Completed,Interventional,2009-12-01,Allergan,Industry,,,4,United States,True,fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution; fixed combination of dorzolamide hydrochloride timolol maleate ophthalmic solution; ,,2011-10-24,15.0,4,True,False,False
NCT00814879,Pilot Study of a Raltegravir Based NRTI Sparing Regimen,Completed,Interventional,2013-05-01,Yale University,Other,Bristol-Myers Squibb Merck Sharp & Dohme Corp.,Industry Industry,,United States,True,Raltegravir; Atazanavir; ,,2015-11-23,60.0,5,True,False,False
NCT00822055,Comparison of the Fixed Combinations of Brimonidine/Timolol and Dorzolamide/Timolol in Subjects With Open-Angle Glaucoma or Ocular Hypertension,Completed,Interventional,2006-11-01,Allergan,Industry,,,4,Canada,True,brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination; dorzolamide hcl 2%/timolol maleate 0.5% fixed combination; brimonidine tartrate 0.2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy; dorzolamide hcl 2%/timolol maleate 0.5% fixed combination as adjunctive to current prostaglandin therapy; ,,,140.0,4,True,False,True
NCT00826280,Caffeine's Effect on Regadenoson Administration With Single Photon Emission Computed Tomography (SPECT) Myocardial Perfusion Imaging (MPI),Completed,Interventional,2010-07-01,Astellas Pharma Inc,Industry,,,3,United States,True,regadenoson; overencapsulated caffeine; placebo; ,,2011-07-08,347.0,3,True,False,False
NCT00829283,Treatment of Obesity and Binge Eating: Behavioral Weight Loss Versus Stepped Care,Completed,Interventional,2013-11-01,Yale University,Other,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,,United States,True,Placebo; Sibutramine/Orlistat; ,,2015-10-27,191.0,5,True,False,False
NCT00834210,Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris,Completed,Interventional,2009-09-01,Allergan,Industry,,,4,United States,True,Dapsone; Tazarotene; ,,2011-09-22,171.0,4,True,False,False
NCT00835198,Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris,Completed,Interventional,2009-08-01,Allergan,Industry,,,4,United States,True,Dapsone; Tretinoin; Tretinoin; ,,2011-09-22,163.0,4,True,False,False
NCT00838981,Pharmacotherapy & CM for Opioid and Cocaine Dependence,Completed,Interventional,2014-03-01,Yale University,Other,National Institute on Drug Abuse (NIDA),NIH,,United States,True,Modafinil; Sugar Pill; ,,,90.0,5,True,True,False
NCT00840645,A Long-term Study of YM178 in Symptomatic Overactive Bladder Patients,Completed,Interventional,2010-03-01,Astellas Pharma Inc,Industry,,,3,Japan,True,YM178; ,,,204.0,3,True,True,False
NCT00842985,Dronabinol Interactions in Humans,Completed,Interventional,2009-10-01,Yale University,Other,VA Office of Research and Development National Institute on Drug Abuse (NIDA),U.S. Fed NIH,,United States,True,Dronabinol + Modafinil; Dronabinol + Placebo; Placebo + Modafinil; Placebo + Placebo; ,,2011-08-05,53.0,5,True,False,False
NCT00850343,Long-term Treatment Study of Certolizumab Pegol Without Coadministration of Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients,Completed,Interventional,2013-05-01,Astellas Pharma Inc,Industry,UCB Japan Co. Ltd.,Industry,3,Japan,True,Certolizumab pegol; ,,2014-09-09,208.0,3,True,False,False
NCT00851318,Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients,Completed,Interventional,2013-06-01,Astellas Pharma Inc,Industry,UCB Japan Co. Ltd.,Industry,3,Japan,True,Certolizumab pegol; Methotrexate; ,,2014-09-09,285.0,3,True,False,False
NCT00858962,Buprenorphine/Raltegravir Pharmacokinetic Interaction Study,Completed,Interventional,2009-12-01,Yale University,Other,National Institute on Drug Abuse (NIDA) Merck Sharp & Dohme Corp.,NIH Industry,,United States,True,Raltegravir; ,,2012-05-31,12.0,5,True,False,False
NCT00860028,Varenicline for Smoking Cessation in Heavy Drinking Smokers,Completed,Interventional,2010-05-01,Yale University,Other,National Institute on Alcohol Abuse and Alcoholism (NIAAA),NIH,2,,True,Varenicline; ,,2012-01-03,30.0,2,True,False,False
NCT00862641,A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary Disease,Completed,Interventional,2009-10-01,Astellas Pharma Inc,Industry,,,4,United States,True,Regadenoson; Placebo; ,,2010-11-15,1009.0,4,True,False,False
NCT00863551,Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART) Trial,Completed,Interventional,2009-08-01,Allergan,Industry,,,4,United States,True,Trospium Chloride; ,,2011-11-16,12.0,4,True,False,False
NCT00863707,A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment,Completed,Interventional,2009-12-01,Astellas Pharma Inc,Industry,,,4,United States,True,Regadenoson; Placebo; ,,2010-12-28,511.0,4,True,False,False
NCT00865137,An Open Study Assessing Bioavailability of a Modified Formulation of Tacrolimus in Kidney Transplant Recipients,Completed,Interventional,2007-12-01,Astellas Pharma Inc,Industry,,,3,Netherlands,True,"Tacrolimus, modified release; ",,,27.0,3,True,True,False
NCT00874887,A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant Organisms,Completed,Interventional,2009-09-01,Allergan,Industry,,,4,Canada United States,True,moxifloxacin 0.5% HCI ophthalmic solution; gatifloxacin ophthalmic solution 0.3%; ,,2011-11-16,66.0,4,True,False,False
NCT00884585,Efficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic Keratoconjunctivitis,Completed,Interventional,2010-10-01,Allergan,Industry,,,3,Australia Canada Czech Republic France Germany India Israel Italy New Zealand Spain United Kingdom United States,True,Cyclosporine Vehicle; Cyclosporine 0.010%; ,,2012-09-27,176.0,3,True,False,False
NCT00892749,Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis,Completed,Interventional,2010-09-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1585; ,,,248.0,3,True,True,False
NCT00907426,Safety and Efficacy Study of Bimatoprost to Treat Hypotrichosis of the Eyelashes After Application to the Eyelid Margin,Completed,Interventional,2010-11-01,Allergan,Industry,,,3,United Kingdom United States,True,Bimatoprost 0.03% solution; Vehicle solution; ,,2012-08-21,368.0,3,True,False,False
NCT00909571,Pharmacokinetics of Tacrolimus in Liver Transplantation Patients Treated With Prograf and Modified Release Tacrolimus,Completed,Interventional,2010-03-01,Astellas Pharma Inc,Industry,"Astellas Pharma Korea, Inc.",Industry,3,"Korea, Republic of",True,FK506E (modified release tacrolimus); Prograf (tacrolimus); ,,,10.0,3,True,True,False
NCT00910520,Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence,Completed,Interventional,2011-08-01,Allergan,Industry,,,3,Belgium Czech Republic Germany Poland Russian Federation United Kingdom United States,True,normal saline; ,,2013-01-29,548.0,3,True,False,False
NCT00910845,Study of Botulinum Toxin Type A for the Treatment of Patients With Idiopathic Overactive Bladder With Urinary Incontinence,Completed,Interventional,2011-07-01,Allergan,Industry,,,3,Canada United States,True,normal saline; ,,2013-01-29,557.0,3,True,False,False
NCT00912964,A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder,Completed,Interventional,2010-04-01,Astellas Pharma Inc,Industry,,,3,Canada Czech Republic Denmark Finland Germany Hungary Norway Slovakia Spain Sweden United States,True,Mirabegron; Placebo; ,,2012-07-17,2030.0,3,True,False,False
NCT00913120,Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Hip Replacement Surgery,Completed,Interventional,2010-03-01,Astellas Pharma Inc,Industry,,,2/3,"Japan Korea, Republic of Taiwan Thailand",True,YM150; Placebo; Enoxaparin; ,,,610.0,2,True,True,False
NCT00913770,"Models of Screening, Brief Intervention With a Facilitated Referral to Treatment (SBIRT) for Opioid Patients in the Emergency Department",Completed,Interventional,2013-08-01,Yale University,Other,National Institute on Drug Abuse (NIDA),NIH,,United States,True,Buprenorphine Initiation; ,,2015-05-11,329.0,5,True,False,False
NCT00917254,Prevention of Venous Thromboembolism in Patients Undergoing Elective Total Knee Replacement Surgery,Completed,Interventional,2010-01-01,Astellas Pharma Inc,Industry,,,2/3,Japan Taiwan Thailand,True,YM150; Placebo; Enoxaparin; ,,,369.0,2,True,True,False
NCT00918411,A Preliminary Study to Explore Clinical Endpoints in Patients (Male) With Diarrhea-predominant Irritable Bowel Syndrome,Completed,Interventional,2009-12-01,Astellas Pharma Inc,Industry,,,4,Japan,True,Ramosetron; Placebo; ,,,98.0,4,True,True,False
NCT00932022,Trospium Chloride XR in Obese Female Patients With Overactive Bladder,Completed,Interventional,2011-12-01,Allergan,Industry,,,4,United States,True,"Trospium Chloride, Extended Release (XR); ",,2012-12-14,127.0,4,True,False,False
NCT00932477,Safety and Tolerability of Artificial Tears in Dry Eye Subjects,Completed,Interventional,2009-09-01,Allergan,Industry,,,,United States,True,"Formulation 1: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear; Formulation 2: Carboxymethylcellulose Sodium, Glycerin and Polysorbate 80, based artificial tear; Glycerin and Polysorbate 80 based artificial tear; ",,2011-11-09,47.0,5,True,False,False
NCT00935493,Guanfacine Treatment for Prefrontal Cognitive Dysfunction in Elderly Subjects,Completed,Interventional,2012-08-01,Yale University,Other,National Institute on Aging (NIA),NIH,,United States,True,Guanfacine; Guanfacine; Placebo; ,,2014-06-18,154.0,5,True,False,False
NCT00937820,Prevention of Recurrence of Venous Thromboembolism in Patients With a History of Venous Thromboembolism,Completed,Interventional,2010-12-01,Astellas Pharma Inc,Industry,,,3,Japan,True,YM150; ,,,87.0,3,True,True,False
NCT00937911,Prevention of Venous Thromboembolism in Subjects Undergoing Hip Fracture Surgery or Surgery in the Lower Extremities,Completed,Interventional,2010-04-01,Astellas Pharma Inc,Industry,,,3,Japan,True,YM150; ,,,101.0,3,True,True,False
NCT00938704,Study to Compare the Efficacy and Safety of Two Non-Preserved Artificial Tears for the Treatment of Dry Eye Signs and Symptoms,Completed,Interventional,2009-06-01,Allergan,Industry,,,4,Germany,True,carboxymethylcellulose 0.5% +glycerin 0.9%; sodium hyaluronate 0.18%; ,,2011-09-22,71.0,4,True,False,False
NCT00938730,A Study Evaluating Safety and Tolerability of YM150 Compared to Warfarin in Subjects With Atrial Fibrillation,Completed,Interventional,2010-09-01,Astellas Pharma Inc,Industry,,,2,"Australia Austria Bulgaria Czech Republic Estonia France Germany Hungary India Israel Japan Korea, Republic of Malaysia Netherlands Philippines Poland Russian Federation Slovakia South Africa Spain Thailand Ukraine United Kingdom",True,YM150; Warfarin; ,,,1280.0,2,True,False,True
NCT00942435,A Study to Assess the Effect of YM150 for Prevention of Venous Thromboembolism in Patients Undergoing Major Abdominal Surgery,Completed,Interventional,2010-04-01,Astellas Pharma Inc,Industry,,,3,Japan,True,YM150; ,,,156.0,3,True,False,True
NCT00956319,A Study to Evaluate Efficacy and Safety of Zolpidem Modified Release Formulation in Insomnia Patients,Completed,Interventional,2010-11-01,Astellas Pharma Inc,Industry,,,4,Taiwan,True,Zolpidem MR; Estazolam; ,,,42.0,4,True,True,False
NCT00958035,Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis,Completed,Interventional,2010-07-01,Allergan,Industry,,,4,United States,True,bimatoprost ophthalmic 0.03% solution; vehicle sterile solution (placebo); ,,2011-11-30,89.0,4,True,False,False
NCT00966004,A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder,Completed,Interventional,2010-02-01,Astellas Pharma Inc,Industry,,,3,Japan,True,YM178; Placebo; tolterodine; ,,,1139.0,3,True,True,False
NCT00972374,Safety and Efficacy of Brimonidine Tartrate Posterior Segment Drug Delivery System in Improving Visual Function,Completed,Interventional,2010-10-01,Allergan,Industry,,,2,"India Israel Korea, Republic of Philippines United Kingdom United States",True,400 ug Brimonidine Implant; 200 ug Brimonidine Implant; ,,2013-03-13,44.0,2,True,False,False
NCT00987727,Safety and Efficacy of Carboxymethylcellulose for Ocular Surface Integrity in Symptomatic Dry Eye,Completed,Interventional,2010-07-01,Allergan,Industry,,,4,France,True,"carboxymethylcellulose 0.5% , glycerin 0.9% (OPTIVE® MD); sodium hyaluronate 0.18% (VISMED® Multi); ",,2011-08-17,82.0,4,True,False,False
NCT00991458,Study of Cyclosporine in Post-LASIK Patients,Completed,Interventional,2011-04-01,Allergan,Industry,,,2,United States,True,Cyclosporine 0.010% eye drops; Cyclosporine 0.005% eye drops; Placebo (Vehicle for Cyclosporine); ,,2013-05-02,621.0,2,True,False,False
NCT00993265,N-Acetylcysteine for Pediatric Trichotillomania,Completed,Interventional,2012-04-01,Yale University,Other,Trichotillomania Learning Center,Other,2,United States,True,N-Acetylcysteine; Placebo; ,,2014-03-07,39.0,2,True,False,False
NCT00995904,Tolerability and PK of Submicron Budesonide in Children 4 to 11 Years Old With Mild-To-Moderate Stable Asthma,Completed,Interventional,2009-11-01,Allergan,Industry,"MAP Pharmaceuticals, Inc., a wholly owned subsidiary of Allergan",Industry,2,United States,True,84ug MAP0020; 42ug MAP0020; 21ug MAP0020; ,,2013-04-17,25.0,2,True,False,False
NCT00996034,Nicotine Vaccination and Nicotinic Receptor Occupancy,Completed,Interventional,2011-02-01,Yale University,Other,Nabi Biopharmaceuticals National Institute on Drug Abuse (NIDA),Industry NIH,2,United States,True,Nicotine bitartrate; ,,2012-09-12,14.0,2,True,False,False
NCT00999219,A Study of FK199B to Compare Efficacy With Zolpidem by Polysomnography in Patients With Insomnia,Completed,Interventional,2007-07-01,Astellas Pharma Inc,Industry,,,3,Japan,True,FK199B; Zolpidem; ,,,55.0,3,True,True,False
NCT01001195,Safety and Efficacy of Three Formulations of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution,Completed,Interventional,2010-04-01,Allergan,Industry,,,2,United States,True,"AGN-210669 ophthalmic solution, 0.1%; AGN-210669 ophthalmic solution, 0.075%; AGN-210669 ophthalmic solution, 0.05%; bimatoprost ophthalmic solution 0.03%; ",,2013-08-13,165.0,2,True,False,False
NCT01010282,Safety and Efficacy of Two Artificial Tears in Dry Eye Subjects,Completed,Interventional,2010-04-01,Allergan,Industry,,,,United States,True,"Glycerin and Polysorbate 80 based artificial tear; Formulation 1: Carboxymethylcellulose sodium, glycerin and Polysorbate 80, based artificial tear; Formulation 2: Carboxymethylcellulose sodium, glycerin, and Polysorbate 80 based artificial tear; ",,2011-11-09,288.0,5,True,False,False
NCT01011205,Phase 3b Study to Evaluate Advagraf in Combination With Mycophenolate Mofetil and Basiliximab in Liver Transplantation,Completed,Interventional,2013-01-01,Astellas Pharma Inc,Industry,,,3,Argentina Austria Belarus Belgium Brazil Canada Colombia Czech Republic Finland France Germany Hungary Ireland Italy Mexico Poland Romania Russian Federation South Africa Spain Sweden Switzerland United Kingdom,True,Advagraf; Mycophenolate Mofetil; Basiliximab; Corticosteroids; ,,,893.0,3,True,True,False
NCT01017276,A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis,Completed,Interventional,2010-09-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1585; ,,,35.0,3,True,True,False
NCT01018914,A Study to Compare Safety and Efficacy of Prograf + Myfortic and Advagraf + Myfortic in Liver Transplantation Patients,Completed,Interventional,2010-12-01,Astellas Pharma Inc,Industry,"Astellas Pharma Taiwan, Inc.",Industry,4,Taiwan,True,Prograf; Advagraf; Myfortic; ,,,44.0,4,True,True,False
NCT01023841,Safety and Efficacy of Bimatoprost Solution in Treating Eyelash Loss or Hypotrichosis in Children,Completed,Interventional,2012-11-01,Allergan,Industry,,,4,Brazil United States,True,bimatoprost ophthalmic solution 0.03%; Vehicle Sterile Solution; ,,2013-07-09,71.0,4,True,False,False
NCT01028950,YM150 for Prevention of Venous Thromboembolism in Patients With Acute Medical Illness,Completed,Interventional,2010-04-01,Astellas Pharma Inc,Industry,,,3,Japan,True,YM150; ,,,52.0,3,True,True,False
NCT01043666,A Study of YM178 in Subjects With Symptoms of Overactive Bladder,Completed,Interventional,2011-09-01,Astellas Pharma Inc,Industry,,,3,"China India Korea, Republic of Taiwan",True,YM178; Placebo; tolterodine ER; ,,,1126.0,3,True,True,False
NCT01044862,Assessment of Multiple Intrauterine Gestations From Ovarian Stimulation,Completed,Interventional,2013-10-01,Yale University,Other,"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Penn State University University of Colorado, Denver University of Michigan University of Pennsylvania University of Texas University of Vermont Wayne State University",NIH Other Other Other Other Other Other Other,3,United States,True,Letrozole (aromatase inhibitor); Clomiphene Citrate; Follicle Stimulating Hormone (gonadotropin); ,,2015-01-06,900.0,3,True,False,False
NCT01054092,A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients,Completed,Interventional,2011-07-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1941; ,,,182.0,3,True,True,False
NCT01057407,A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis,Completed,Interventional,2010-09-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1585; Sevelamer hydrochloride; ,,,110.0,3,True,True,False
NCT01057628,A Study to Assess the Efficacy and Safety of ASP1941 in Japanese Type 2 Diabetes Patients,Completed,Interventional,2010-12-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1941; placebo; ,,,130.0,3,True,False,True
NCT01058174,Liver Transplant European Study Into the Prevention of Fungal Infection,Completed,Interventional,2012-05-01,Astellas Pharma Inc,Industry,,,3,Austria Belgium France Germany Hungary Ireland Italy Portugal Romania Russian Federation Saudi Arabia Spain Sweden United Kingdom,True,micafungin; fluconazole; liposomal amphotericin B; caspofungin; ,,,350.0,3,True,False,True
NCT01064882,Safety and Efficacy of Bimatoprost Ophthalmic Solution in Increasing Eyelash Prominence,Completed,Interventional,2010-07-01,Allergan,Industry,,,2,United States,True,bimatoprost ophthalmic solution 0.005%; bimatoprost ophthalmic solution 0.015%; bimatoprost ophthalmic solution 0.03%; ,,2011-08-18,104.0,2,True,False,False
NCT01068964,Safety and Efficacy of Bimatoprost Timolol Ophthalmic Solution in Patients With Open Angle Glaucoma or Ocular Hypertension,Completed,Interventional,2010-09-01,Allergan,Industry,,,,China,True,0.03% Bimatoprost/0.5% Timolol Ophthalmic Solution; 0.03% Bimatoprost Ophthalmic Solution and 0.5% Timolol Ophthalmic Solution; ,,2011-12-16,235.0,5,True,False,False
NCT01080209,Safety Extension Study to Evaluate the Biodegradation of the Brimonidine Tartrate Posterior Segment Drug Delivery System,Completed,Interventional,2014-02-01,Allergan,Industry,,,2,"Australia Czech Republic France Germany India Israel Italy Korea, Republic of Philippines Portugal United Kingdom United States",True,Brimo PS DDS®; ,,2015-02-05,215.0,2,True,False,False
NCT01089751,Efficacy of Sanctura XR (Trospium Chloride) for Reducing Overactive Bladder Symptoms in Female Subjects Refractory to Detrol LA (Tolterodine Tartrate Extended Release) Daily,Completed,Interventional,2012-06-01,Allergan,Industry,,,4,United States,True,trospium chloride; placebo; ,,2013-06-12,322.0,4,True,False,False
NCT01093534,Study of 2 Doses of Solifenacin Succinate in Female Subjects With Overactive Bladder.,Completed,Interventional,2011-06-01,Astellas Pharma Inc,Industry,,,4,Austria Belgium Bulgaria Canada Czech Republic France Germany Hungary Israel Italy Norway Poland Romania Russian Federation Slovakia Spain Sweden Turkey United Kingdom United States,True,Placebo; solifenacin; ,,2014-02-26,547.0,4,True,False,False
NCT01099774,Safety and Efficacy of Different Formulations of Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,Completed,Interventional,2011-04-01,Allergan,Industry,,,3,United States,True,Bimatoprost 0.03% Formulation B Ophthalmic Solution; Bimatoprost 0.03% Ophthalmic Solution; ,,2012-04-03,597.0,3,True,False,False
NCT01107392,Safety and Efficacy of Botulinum Toxin Type A to Treat Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia,Completed,Interventional,2012-03-01,Allergan,Industry,,,2,"Canada Czech Republic France Germany Korea, Republic of Philippines Poland United States",True,botulinum toxin Type A; Normal saline; ,,2014-02-24,315.0,2,True,False,False
NCT01109056,Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium,Completed,Interventional,2011-05-01,Allergan,Industry,,,2,Australia Singapore United States,True,cyclosporine ophthalmic emulsion 0.05%; Vehicle; ,,2012-05-22,115.0,2,True,False,False
NCT01110499,Safety and Efficacy of AGN-210961 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,Completed,Interventional,2011-05-01,Allergan,Industry,,,2,United States,True,AGN-210961 Formulation 1; AGN-210961 Formulation 2; AGN-210961 Formulation 3; AGN-210961 Formulation 4; AGN-210961 Formulation 5; AGN-210961 Formulation 6; AGN-210961 Formulation 7; bimatoprost ophthalmic solution 0.03%; ,,2013-05-31,163.0,2,True,False,False
NCT01118572,A Study to Verify the Efficacy of YM177 (Celecoxib) in Postoperative Pain Patients,Completed,Interventional,2010-11-01,Astellas Pharma Inc,Industry,,,3,Japan,True,YM177; etodolac; Placebo; ,,,616.0,3,True,True,False
NCT01122368,A Study to Evaluate Pre-emptive Treatment for Invasive Candidiasis in High Risk Surgical Subjects,Completed,Interventional,2011-12-01,Astellas Pharma Inc,Industry,,,2,Austria Belgium Denmark Finland France Germany Greece Hungary Israel Italy Romania Spain Switzerland Turkey United Kingdom,True,micafungin; placebo; ,,,252.0,2,True,False,True
NCT01126424,A Study to Compare Two Medications With an Inactive Medication and Look at the Effect on a Person's Mental Ability,Completed,Interventional,2010-12-01,Astellas Pharma Inc,Industry,,,4,United Kingdom,True,Solifenacin; Oxybutynin; Placebo; ,,2012-07-05,26.0,4,True,False,False
NCT01129531,A Study of the Safety and Efficacy of AGN-214868 in Patients With Postherpetic Neuralgia,Completed,Interventional,2011-10-01,Allergan,Industry,,,2,Czech Republic Germany Poland United States,True,AGN-214868; Placebo to AGN-214868; ,,2013-09-12,294.0,2,True,False,False
NCT01135433,A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Type 2 Diabetic Patients,Completed,Interventional,2011-12-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1941; Placebo; metformin; ,,,168.0,3,True,False,True
NCT01145001,Enhancing a High School Based Smoking Cessation Program,Completed,Interventional,2014-07-01,Yale University,Other,National Institutes of Health (NIH),NIH,,United States,True,Nicotine Transdermal Patch; ,,2016-08-24,169.0,5,True,False,False
NCT01153581,Sex Hormones and Orthostatic Tolerance,Completed,Interventional,2012-12-01,Yale University,Other,,,2,United States,True,"17 beta estradiol, progesterone, ganirelix acetate; 17 beta estradiol, progesterone, ganirelix acetate; ",,,62.0,2,True,True,False
NCT01157377,Safety and Efficacy Study of AGN-214868 in Patients With Idiopathic Overactive Bladder and Urinary Incontinence,Completed,Interventional,2013-02-01,Allergan,Industry,,,2,France Netherlands United States,True,AGN-214868; AGN-214868 placebo; ,,2014-02-04,160.0,2,True,False,False
NCT01170884,Comparing Safety and Efficacy of Combigan® and Lumigan® With Lumigan® Alone in Glaucoma or Ocular Hypertension Subjects Treated With Xalatan®,Completed,Interventional,2010-09-01,Allergan,Industry,,,4,United States,True,fixed combination of brimonidine tartrate 0.2% timolol maleate 0.5% ophthalmic solution; bimatoprost 0.03% ophthalmic solution; bimatoprost 0.03% ophthalmic solution; hypromellose 0.2% eyedrops; ,,2011-12-07,121.0,4,True,False,False
NCT01172288,N-acetylcysteine (NAC) for Children With Tourette Syndrome,Completed,Interventional,2014-01-01,Yale University,Other,American Academy of Child Adolescent Psychiatry.,Other,2,United States,True,N-Acetylcysteine (NAC); Placebo; ,,,31.0,2,True,True,False
NCT01177098,Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular Hypertension,Completed,Interventional,2012-02-01,Allergan,Industry,,,3,Australia Czech Republic Germany Hungary Israel Russian Federation Spain United Kingdom United States,True,bimatoprost /timolol formulation A fixed combination ophthalmic solution; bimatoprost/timolol fixed combination ophthalmic solution; ,,2013-02-07,561.0,3,True,False,False
NCT01178827,Sanctura Muscarinic Receptor Antagonist Resists Transport (SMART-II) Trial,Completed,Interventional,2011-03-01,Allergan,Industry,,,4,United States,True,trospium chloride; oxybutynin IR; oxybutynin IR placebo; ,,2012-03-23,20.0,4,True,False,False
NCT01181232,A Study to Compare Efficacy and Safety of Zolpidem Modified Release Formulation Versus Zolpidem in Insomnia Patients,Completed,Interventional,2011-04-01,Astellas Pharma Inc,Industry,"Astellas Pharma Taiwan, Inc.",Industry,4,Taiwan,True,Zolpidem MR; Zolpidem IR; ,,,132.0,4,True,True,False
NCT01189747,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines,Completed,Interventional,2011-04-01,Allergan,Industry,,,3,Belgium Canada United Kingdom United States,True,normal saline; ,,2013-09-27,446.0,3,True,False,False
NCT01189760,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines,Completed,Interventional,2011-03-01,Allergan,Industry,,,3,Canada France Germany United States,True,normal saline; ,,2013-09-27,917.0,3,True,False,False
NCT01194479,Effect of Formoterol on the Counterregulatory Hormonal Response to Hypoglycemia in Type 1 Diabetes.,Completed,Interventional,2014-08-01,Yale University,Other,National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK),NIH,,United States,True,Formoterol; ,,2016-01-28,14.0,5,True,False,False
NCT01209845,Ketamine for Low Mood States in the ER,Completed,Interventional,2010-12-01,Yale University,Other,,,,United States,True,ketamine; ,,,14.0,5,True,True,False
NCT01216943,Safety and Efficacy of Triple Combination Therapy in Patients With Glaucoma or Ocular Hypertension,Completed,Interventional,2012-08-01,Allergan,Industry,,,3,India,True,bimatoprost/brimonidine tartrate/timolol fixed combination ophthalmic solution; ,,2013-07-16,126.0,3,True,False,False
NCT01217606,Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension,Completed,Interventional,2014-09-01,Allergan,Industry,,,3,Brazil,True,bimatoprost/brimonidine tartrate/timolol ophthalmic solution (Triple Combination Therapy); Fixed Combination 0.2% brimonidine tartrate/0.5% timolol ophthalmic solution; ,,2015-10-12,185.0,3,True,False,False
NCT01224015,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Crow's Feet Lines and Frown Lines,Completed,Interventional,2011-10-01,Allergan,Industry,,,3,Canada France Germany United States,True,normal saline; ,,2013-09-27,684.0,3,True,False,False
NCT01224028,A Study to Evaluate the Efficacy and Safety of Tacrolimus in Korean Nephropathy Patients,Completed,Interventional,2011-06-01,Astellas Pharma Inc,Industry,"Astellas Pharma Korea, Inc.",Industry,2,"Korea, Republic of",True,Tacrolimus; Placebo; ,,,40.0,2,True,False,True
NCT01224041,Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate,Completed,Interventional,2011-06-01,Astellas Pharma Inc,Industry,"Astellas Pharma Korea, Inc.",Industry,4,"Korea, Republic of",True,Tacrolimus; ,,,78.0,4,True,True,False
NCT01224418,A Study to Evaluate the Efficacy of Tacrolimus in Rheumatoid Arthritis Patients Shown Unsuccessful Response to Methotrexate,Completed,Interventional,2009-08-01,Astellas Pharma Inc,Industry,"Astellas Pharma Korea, Inc.",Industry,4,"Korea, Republic of",True,Tacrolimus; ,,,50.0,4,True,True,False
NCT01225081,A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Pioglitazone in Type 2 Diabetic Patients,Completed,Interventional,2012-04-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1941; Placebo; Pioglitazone; ,,,152.0,3,True,False,True
NCT01225237,A Study to Evaluate Efficacy of Ramosetron on Diarrhea-predominant Irritable Bowel Syndrome (IBS) in Male Patients,Completed,Interventional,2011-08-01,Astellas Pharma Inc,Industry,,,4,Japan,True,Ramosetron; Placebo; ,,,296.0,4,True,False,True
NCT01229423,Safety and Efficacy of LATISSE® in the Augmentation of Eyelashes of Korean Subjects,Completed,Interventional,2010-06-01,Allergan,Industry,,,4,"Korea, Republic of",True,bimatoprost 0.03%; ,,2011-12-16,62.0,4,True,False,False
NCT01229462,Safety and Efficacy of Brimonidine Tartrate/Timolol Fixed Combination in Patients With Glaucoma or Ocular Hypertension,Completed,Interventional,2011-09-01,Allergan,Industry,,,,China,True,brimonidine tartrate/timolol fixed combination ophthalmic solution; brimonidine tartrate ophthalmic solution; timolol ophthalmic solution; ,,2012-08-15,238.0,5,True,False,False
NCT01231334,A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne,Completed,Interventional,2011-06-01,Allergan,Industry,,,4,United States,True,Dapsone plus Adapalene; Clindamycin/benzoyl peroxide plus Adapalene; ,,2012-06-25,286.0,4,True,False,False
NCT01232790,A Pilot Trial of Acute N-Acetylcysteine Effects on Working Memory and Other Cognitive Functions in Schizophrenia,Completed,Interventional,2011-11-01,Yale University,Other,National Alliance for Research on Schizophrenia and Depression,Other,,United States,True,Placebo; ,,2013-01-24,28.0,5,True,False,False
NCT01238575,Guanfacine for the Treatment of Hyperactivity in Pervasive Developmental Disorder,Completed,Interventional,2014-03-01,Yale University,Other,"Emory University Massachusetts General Hospital Seattle Children's Hospital University of California, Los Angeles National Institute of Mental Health (NIMH)",Other Other Other Other NIH,4,United States,True,extended-release guanfacine; ,,2015-04-30,62.0,4,True,False,False
NCT01241240,Safety and Efficacy of Triple Combination Therapy in Patients With Primary Open-Angle Glaucoma or Ocular Hypertension,Completed,Interventional,2013-09-01,Allergan,Industry,,,3,Colombia Mexico,True,bimatoprost/brimonidine tartrate/timolol ophthalmic solution (Triple Combination Therapy); Fixed Combination 0.2% brimonidine tartrate/0.5% timolol ophthalmic solution; ,,2014-09-04,192.0,3,True,False,False
NCT01242202,A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients,Completed,Interventional,2012-05-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1941; alpha glucosidase inhibitor; ,,,113.0,3,True,True,False
NCT01242215,A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients,Completed,Interventional,2012-04-01,Astellas Pharma Inc,Industry,,,3,Japan,True,Placebo; Sulfonylurea; ,,,243.0,3,True,False,True
NCT01242228,A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients,Completed,Interventional,2012-06-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1941; DPP-4 inhibitor; ,,,106.0,3,True,True,False
NCT01243567,Safety and Efficacy of Bimatoprost/Timolol Fixed Combination Versus Latanoprost in Patients With Open-Angle Glaucoma Who Have Never Been Treated,Completed,Interventional,2012-02-01,Allergan,Industry,,,4,Portugal Spain,True,bimatoprost 0.03%/timolol 0.5% combination ophthalmic solution; latanoprost 0.005% ophthalmic solution; ,,2013-01-22,81.0,4,True,False,False
NCT01249274,Progesterone for Postpartum Cocaine Relapse,Completed,Interventional,2013-07-01,Yale University,Other,National Institute on Drug Abuse (NIDA),NIH,,United States,True,Progesterone; ,,,50.0,5,True,True,False
NCT01252160,Safety and Effectiveness of Repeated Administration of QUTENZA Patches for Treatment of Pain Caused by Nerve Damage,Completed,Interventional,2013-09-01,Astellas Pharma Inc,Industry,,,4,Austria Belgium Czech Republic Finland France Greece Hungary Ireland Italy Netherlands Poland Romania Slovakia Slovenia Spain United Kingdom,True,QUTENZA; ,,,306.0,4,True,True,False
NCT01253902,Ocular Surface Tolerability Study of Prostaglandin Analogues in Patients With Open-Angle Glaucoma or Ocular Hypertension,Completed,Interventional,2011-10-01,Allergan,Industry,,,4,Canada United States,True,bimatoprost ophthalmic solution 0.01%; travoprost ophthalmic solution 0.004%; latanoprost ophthalmic solution 0.005%; ,,2012-10-08,164.0,4,True,False,False
NCT01258309,Safety and Efficacy of Olopatadine Hydrochloride/Ketorolac Tromethamine Ophthalmic Solution Compared With Olopatadine Hydrochloride Ophthalmic Solution in Patients With Seasonal Allergic Conjunctivitis,Completed,Interventional,2011-01-01,Allergan,Industry,,,3,India,True,olopatadine hydrochloride /ketorolac tromethamine fixed dose combination ophthalmic solution; olopatadine hydrochloride 0.1% ophthalmic solution; ,,,129.0,3,True,True,False
NCT01259466,Internet-Administered Smoking Cessation Treatment for Overweight and Obese Smokers,Completed,Interventional,2013-11-01,Yale University,Other,American Heart Association,Other,,United States,True,Nicotine patch; ,,2015-07-16,54.0,5,True,False,False
NCT01261572,Study to Find Maintenance Dose for Periodic Administration of ASP3550,Completed,Interventional,2012-04-01,Astellas Pharma Inc,Industry,,,2,Japan,True,ASP3350; ,,,155.0,2,True,True,False
NCT01274000,A Study to Evaluate Efficacy of YM060 on Diarrhea-predominant Irritable Bowel Syndrome (D-IBS) in Female Patients,Completed,Interventional,2011-10-01,Astellas Pharma Inc,Industry,,,2,Japan,True,YM060; placebo; ,,,409.0,2,True,True,False
NCT01291108,Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension,Completed,Interventional,2011-10-01,Allergan,Industry,,,2,United States,True,AGN-210669; bimatoprost; bimatoprost vehicle; ,,2013-08-13,125.0,2,True,False,False
NCT01294384,Safety and Efficacy Study of New Eye Drop Formulations With Refresh Tears® in Patients With Dry Eye Disease,Completed,Interventional,2012-09-01,Allergan,Industry,,,3,Australia Canada,True,carboxymethylcellulose sodium based New Eye Drop Formulation 1; carboxymethylcellulose sodium based New Eye Drop Formulation 2; carboxymethylcellulose sodium based Eye Drops; ,,2013-09-24,305.0,3,True,False,False
NCT01304836,A Study Looking at Diabetes in Kidney Transplant Recipients Receiving Immunosuppressive Regimen With or Without Steroids,Completed,Interventional,2013-05-01,Astellas Pharma Inc,Industry,,,4,"Australia Belgium Colombia Czech Republic Estonia Finland France Germany Hungary Italy Korea, Republic of Latvia Lithuania Mexico Netherlands Norway Poland Portugal Romania Russian Federation Slovakia Spain Sweden Switzerland",True,Advagraf; Mycophenolate Mofetil; Simulect; Corticosteroids; ,,,1166.0,4,True,True,False
NCT01316094,A Study to Assess Efficacy and Safety of ASP1941 in Diabetic Patients With Renal Impairment,Completed,Interventional,2012-11-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1941; placebo; ,,,165.0,3,True,True,False
NCT01316107,A Study to Assess Safety and Efficacy of ASP1941 in Combination With Nateglinide in Type 2 Diabetic Patients,Completed,Interventional,2012-12-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1941; nateglinide; ,,,122.0,3,True,True,False
NCT01318837,A Study to Evaluate Response of Over Active Bladder Symptom Score to Solifenacin Treatment,Completed,Interventional,2011-09-01,Astellas Pharma Inc,Industry,"Astellas Pharma Korea, Inc.",Industry,4,"Korea, Republic of",True,solifenacin; ,,,100.0,4,True,True,False
NCT01325337,Safety and Efficacy Study of Bimatoprost in the Treatment of Men With Androgenic Alopecia,Completed,Interventional,2012-08-01,Allergan,Industry,,,2,Germany United States,True,bimatoprost Formulation A; bimatoprost Formulation B; bimatoprost Formulation C; bimatoprost vehicle solution; minoxidil 5% solution; ,,2014-03-03,307.0,2,True,False,False
NCT01325350,Safety and Efficacy Study of Bimatoprost in the Treatment of Women With Female Pattern Hair Loss,Completed,Interventional,2012-07-01,Allergan,Industry,,,2,Germany United States,True,bimatoprost Formulation A; bimatoprost Formulation B; bimatoprost Formulation C; bimatoprost vehicle solution; minoxidil 2% solution; ,,2014-03-03,306.0,2,True,False,False
NCT01325571,A Study to Compare the Efficacy and Safety of Tacrolimus Capsules in Patient With Myasthenia Gravis,Completed,Interventional,2014-05-01,Astellas Pharma Inc,Industry,"Astellas Pharma China, Inc.",Industry,3,China,True,Tacrolimus capsule; Placebo; ,,,83.0,3,True,True,False
NCT01332201,Study to Compare the Pharmacokinetics of Tacrolimus in Adult Transplant Recipients Treated With Advagraf® or Prograf®,Completed,Interventional,2013-11-01,Astellas Pharma Inc,Industry,,,2,Austria Belgium France Italy Taiwan United Kingdom,True,Advagraf; Prograf; ,,,17.0,2,True,True,False
NCT01334918,A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT),Completed,Interventional,2012-07-01,Astellas Pharma Inc,Industry,,,2,United States,True,regadenoson; ,,2013-07-11,124.0,2,True,False,False
NCT01339468,"A Study to Assess the Pharmacokinetics, Safety and Efficacy of Advagraf and Prograf in de Novo Liver Transplantation",Completed,Interventional,2014-05-01,Astellas Pharma Inc,Industry,,,4,"Korea, Republic of",True,Advagraf; Prograf; Prograf; ,,,100.0,4,True,True,False
NCT01349231,Ketamine Infusion for Obsessive-Compulsive Disorder,Completed,Interventional,2011-12-01,Yale University,Other,National Alliance for Research on Schizophrenia and Depression,Other,2,United States,True,ketamine; ,,2014-03-04,10.0,2,True,False,False
NCT01363752,A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.,Completed,Interventional,2013-09-01,Astellas Pharma Inc,Industry,,,4,"Australia Austria Belarus Belgium Czech Republic France Germany Hong Kong Hungary Italy Korea, Republic of Netherlands Poland Russian Federation Spain Taiwan Turkey",True,Advagraf; Mycophenolate Mofetil; Sirolimus; Corticosteroids; ,,,853.0,4,True,True,False
NCT01371994,A Study to Assess Efficacy and Safety With Solifenacin Succinate to Improve Urinary Continence After Robotic Assisted Radical Prostatectomy,Completed,Interventional,2013-10-01,Astellas Pharma Inc,Industry,,,4,Canada United States,True,solifenacin succinate; Placebo; ,,2014-10-06,640.0,4,True,False,False
NCT01391273,Safety and Efficacy Study of Bimatoprost in Japanese Patients With Eyelash Hypotrichosis,Completed,Interventional,2012-05-01,Allergan,Industry,,,3,Japan,True,bimatoprost solution 0.03%; bimatoprost vehicle solution; ,,2013-05-21,173.0,3,True,False,False
NCT01391286,Safety and Efficacy Study of Bimatoprost in Japanese Patients With Chemotherapy-Induced Eyelash Hypotrichosis,Completed,Interventional,2012-05-01,Allergan,Industry,,,3,Japan,True,bimatoprost solution 0.03%; bimatoprost vehicle solution; ,,2013-05-21,36.0,3,True,False,False
NCT01391299,Safety and Efficacy Study of Botulinum Toxin Type A for the Treatment of Forehead and Frown Lines,Completed,Interventional,2011-10-01,Allergan,Industry,,,,Canada,True,Normal Saline; ,,2012-10-26,175.0,5,True,False,False
NCT01391312,Patient Satisfaction Study of BOTOX® Cosmetic in the Treatment of Moderate to Severe Frown Lines,Completed,Interventional,2011-10-01,Allergan,Industry,,,4,United States,True,normal saline (placebo); ,,2012-08-24,40.0,4,True,False,False
NCT01391338,"A Clinical Study to Investigate the Efficacy, Safety and Pharmacokinetics of ASP3652 in Patients With Chronic Abacterial Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS)",Completed,Interventional,2013-02-01,Astellas Pharma Inc,Industry,,,2,Czech Republic Germany Latvia Lithuania Poland Spain,True,ASP3652; Placebo; ,,,239.0,2,True,True,False
NCT01397409,Evaluation of AGN-150998 in Exudative Age-related Macular Degeneration (AMD),Completed,Interventional,2014-03-01,Allergan,Industry,,,2,Australia Austria France Germany Israel Italy Switzerland United States,True,AGN-150998; ranibizumab; ,,2015-06-02,271.0,2,True,False,False
NCT01416116,Method of Pre-treatment for Application of QUTENZA Capsaicin 8% Patch,Completed,Interventional,2012-04-01,Astellas Pharma Inc,Industry,,,4,Belgium Czech Republic Denmark Ireland Norway Slovakia United Kingdom,True,QUTENZA; Lidocaine; Tramadol; ,,,122.0,4,True,True,False
NCT01448525,Study Assessing Patient Satisfaction With LATISSE® for Increasing Eyelash Prominence,Completed,Interventional,2012-04-01,Allergan,Industry,,,4,United States,True,bimatoprost ophthalmic solution 0.03%; bimatoprost vehicle solution; ,,2013-04-05,88.0,4,True,False,False
NCT01451203,Efficacy Confirmation Study of CDP870 in Early Rheumatoid Arthritis,Completed,Interventional,2013-08-01,Astellas Pharma Inc,Industry,UCB Japan Co. Ltd.,Industry,3,Japan,True,Placebo; CZP; methotrexate (MTX); ,,2015-10-18,319.0,3,True,False,False
NCT01459588,"Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease",Completed,Interventional,2012-02-01,Allergan,Industry,,,3,United States,True,Carboxymethylcellulose Based Eye Drop Formulation A; Carboxymethylcellulose Based Eye Drop Formulation B; Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops; Carboxymethylcellulose Based Lubricant Eye Drops; ,,2013-02-11,315.0,3,True,False,False
NCT01462227,Effect of Naltrexone on Counterregulatory Mechanisms in Hypoglycemia,Completed,Interventional,2013-10-01,Yale University,Other,National Institutes of Health (NIH),NIH,,United States,True,Naltrexone High Dose; Naltrexone Low Dose; ,,2016-01-20,17.0,5,True,False,False
NCT01470118,A Study to Evaluate the Duration of LASTACAFT® in Acute Allergic Conjunctivitis,Completed,Interventional,2011-12-01,Allergan,Industry,,,4,United States,True,alcaftadine 0.25% ophthalmic solution; olopatadine 0.2% ophthalmic solution; dextran 70 0.1%/hydroxypropyl methylcellulose 0.3%; ,,2012-12-13,127.0,4,True,False,False
NCT01472874,Single Daily Dosage of Trientine for Maintenance Treatment for Wilson Disease,Completed,Interventional,2011-07-01,Yale University,Other,"Valeant Pharmaceuticals International, Inc.",Industry,,United States,True,Once a day Trientine; ,,2014-04-21,8.0,5,True,False,False
NCT01478607,A Study to Evaluate the Long-term Safety of Repeated QUTENZA Administration for Treatment of Pain Caused by Nerve Damage in Diabetic Patients,Completed,Interventional,2014-02-01,Astellas Pharma Inc,Industry,,,3,Belgium Czech Republic France Germany Italy Netherlands Poland Russian Federation Spain Ukraine United Kingdom,True,QUTENZA; ,,,468.0,3,True,True,False
NCT01492400,Safety and Efficacy Study of Dexamethasone Versus Ranibizumab in Patients With Diabetic Macular Edema,Completed,Interventional,2014-02-01,Allergan,Industry,,,2,Belgium Denmark France Germany Israel Italy Netherlands Portugal South Africa Spain United Kingdom United States,True,dexamethasone Intravitreal Implant; ranibizumab; ,,2015-01-21,363.0,2,True,False,False
NCT01498549,Cognitive Effects of Atomoxetine in Humans: Genetic Moderators,Completed,Interventional,2013-07-01,Yale University,Other,,,,United States,True,Atomoxetine; Sugar Pill; ,,,35.0,5,True,True,False
NCT01505426,A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Metformin in Asian Diabetes Patients,Completed,Interventional,2013-01-01,Astellas Pharma Inc,Industry,,,3,"Korea, Republic of Taiwan",True,ASP1941; metformin; Placebo; ,,,171.0,3,True,True,False
NCT01525173,A Safety and Efficacy Study of ALPHAGAN® P and LUMIGAN® in Subjects Previously Treated With Latanoprost for Glaucoma and Ocular Hypertension,Completed,Interventional,2012-10-01,Allergan,Industry,,,4,United States,True,0.1% brimonidine tartrate ophthalmic solution; 0.01% bimatoprost ophthalmic solution; 0.2% hypromellose lubricant eye drops; latanoprost 0.005% ophthalmic solution; ,,2013-10-07,137.0,4,True,False,False
NCT01533428,A Study to Evaluate Efficacy and Safety of a Single Application of Capsaicin 8%Transdermal Delivery System Compared to Placebo in Reducing Pain Intensity in Subjects With Painful Diabetic Peripheral Neuropathy (PDPN),Completed,Interventional,2014-02-01,Astellas Pharma Inc,Industry,,,3,United States,True,Capsaicin 8%; Placebo; ,,2015-02-06,369.0,3,True,False,False
NCT01547598,Safety and Efficacy of LUMIGAN® RC Versus DuoTrav® in Patients Who Require Further Intraocular Pressure (IOP) Reduction,Completed,Interventional,2013-07-01,Allergan,Industry,,,4,Canada,True,travoprost ophthalmic solution 0.004%; travoprost 0.004% / timolol 0.5% combination ophthalmic solution; Bimatoprost ophthalmic solution 0.01%; ,,2014-07-28,135.0,4,True,False,False
NCT01575054,BOTOX® Treatment in Adult Patients With Post-Stroke Lower Limb Spasticity,Completed,Interventional,2014-09-01,Allergan,Industry,,,3,"Canada Czech Republic Germany Hungary Korea, Republic of Poland Russian Federation United Kingdom United States",True,Normal Saline; ,,2015-10-01,468.0,3,True,False,False
NCT01594970,A Safety and Efficacy Study of Bimatoprost 0.01% in Primary Open-Angle Glaucoma (POAG) or Ocular Hypertension (OH),Completed,Interventional,2013-01-01,Allergan,Industry,,,4,"Korea, Republic of",True,Bimatoprost 0.01%; ,,2014-01-27,800.0,4,True,False,False
NCT01600716,Safety and Efficacy Study of OnabotulinumtoxinA for the Treatment of Urinary Incontinence Due to Neurogenic Detrusor Overactivity (NDO) in Non-Catheterizing Patients With Multiple Sclerosis (MS),Completed,Interventional,2014-04-01,Allergan,Industry,,,3,Belgium Canada Czech Republic France Poland Portugal Russian Federation United States,True,Placebo (Normal Saline); ,,2016-02-17,144.0,3,True,False,False
NCT01600885,The Effects of Ketamine and Guanfacine on Working Memory in Healthy Subjects,Completed,Interventional,2011-07-01,Yale University,Other,VA Office of Research and Development,U.S. Fed,,United States,True,Guanfacine; Placebo; ,,2014-08-29,19.0,5,True,False,False
NCT01613248,A Dose-Finding Study of MK-1602 in the Treatment of Acute Migraine (MK-1602-006),Completed,Interventional,2012-12-01,Allergan,Industry,,,2,,True,MK-1602; Placebo-matching MK-1602; Rescue medication; ,,2016-08-08,834.0,2,True,False,False
NCT01649999,A Study to Evaluate the Efficacy and Safety of ASP015K in Moderate to Severe Rheumatoid Arthritis Subjects,Completed,Interventional,2013-07-01,Astellas Pharma Inc,Industry,,,2,Japan,True,ASP015K; Placebo; ,,,281.0,2,True,False,True
NCT01660802,Safety and Efficacy Study of Dexamethasone in the Treatment of Patients With Macular Edema Following Retinal Vein Occlusion (RVO),Completed,Interventional,2014-03-01,Allergan,Industry,,,3,China,True,700 μg Dexamethasone; ,,2015-04-02,262.0,3,True,False,False
NCT01664949,A Study to Compare the Safety and Efficacy of A New Eye Drop Formulation With OPTIVE™ in Subjects With Dry Eye Disease,Completed,Interventional,2014-05-01,Allergan,Industry,,,3,Australia Belgium France Germany Italy Russian Federation Spain United Kingdom,True,Carboxymethylcellulose Based Eye Drop Formulation A; Carboxymethylcellulose Based Preservative-Free Lubricant Eye Drops; ,,2015-05-22,460.0,3,True,False,False
NCT01672762,A Study to Evaluate Long-term Safety and Efficacy of ASP1941 in Diabetes Patients,Completed,Interventional,2013-04-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1941; ,,,174.0,3,True,True,False
NCT01698554,Bimatoprost in the Treatment of Eyelash Hypotrichosis,Completed,Interventional,2014-02-01,Allergan,Industry,,,3,Russian Federation Sweden United Kingdom United States,True,bimatoprost formulation A solution; bimatoprost solution 0.03 %; vehicle of bimatoprost formulation A solution; vehicle of bimatoprost solution 0.03 %; ,,2015-01-27,464.0,3,True,False,False
NCT01699607,Test-retest Reproducibility of [11C]PHNO PET Using the Constant Infusion Paradigm,Completed,Interventional,2013-07-01,Yale University,Other,,,,United States,True,Amphetamine; ,,2015-07-14,10.0,5,True,False,False
NCT01714609,Pilot Study of Effect of Sorafenib on Portal Pressure,Completed,Interventional,2013-09-01,Yale University,Other,"Onyx Therapeutics, Inc.",Industry,2,United States,True,Placebo; Sorafenib; ,,2015-11-03,10.0,2,True,False,False
NCT01714843,A Study to Evaluate the Effect of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome,Completed,Interventional,2013-12-01,Astellas Pharma Inc,Industry,,,2,Japan,True,ASP0456; placebo; ,,,559.0,2,True,True,False
NCT01725282,Study to Evaluate the Effect and Safety of Quetiapine Extended Release (XR) (FK949E) in Major Depressive Disorder,Completed,Interventional,2013-08-01,Astellas Pharma Inc,Industry,,,2,Japan,True,quetiapine extended release (XR); Placebo; ,,2014-08-14,172.0,2,True,False,False
NCT01732757,A Study to Evaluate the Efficacy of Lastacaft® Compared to Pataday™ and Placebo in Patients With Acute Allergic Conjunctivitis,Completed,Interventional,2012-12-01,Allergan,Industry,,,4,United States,True,Alcaftadine 0.25%; Olopatadine 0.2%; dextran 70 0.1%/hydroxypropyl methylcellulose 0.3%; ,,2013-11-27,157.0,4,True,False,False
NCT01735201,AGN-199201 for the Treatment of Erythema With Rosacea,Completed,Interventional,2013-05-01,Allergan,Industry,,,2,United States,True,AGN-199201 Dose A; AGN-199201 Dose B; AGN-199201 Dose C; AGN-199201 Vehicle; ,,2014-05-02,357.0,2,True,False,False
NCT01736423,A Long Term Study of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome,Completed,Interventional,2014-05-01,Astellas Pharma Inc,Industry,,,3,Japan,True,YM060; ,,,151.0,3,True,True,False
NCT01742585,A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis,Completed,Interventional,2014-05-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP1585; placebo; ,,,163.0,3,True,True,False
NCT01745094,A Study to Evaluate the Effect of Mirabegron + Solifenacin in Overactive Bladder Patients,Completed,Interventional,2013-07-01,Astellas Pharma Inc,Industry,,,4,Japan,True,mirabegron; solifenacin; ,,,223.0,4,True,True,False
NCT01754766,AGN-229666 for the Treatment of Allergic Conjunctivitis,Completed,Interventional,2013-01-01,Allergan,Industry,,,2,Japan,True,AGN-229666; ,,2013-12-17,90.0,2,True,False,False
NCT01765764,Bimatoprost for the Treatment of Eyebrow Hypotrichosis,Completed,Interventional,2014-01-01,Allergan,Industry,,,3,Canada United States,True,bimatoprost solution; Vehicle to bimatoprost solution; ,,2015-01-16,357.0,3,True,False,False
NCT01767519,A Study Evaluating the Efficacy and Safety of BOTOX® or Solifenacin in Patients With Overactive Bladder and Urinary Incontinence,Completed,Interventional,2014-09-01,Allergan,Industry,,,3,Belgium Canada Czech Republic Germany Poland United Kingdom United States,True,solifenacin; Botox placebo (normal saline); solifenacin placebo; ,,2015-10-21,356.0,3,True,False,False
NCT01777620,A Study of Subject Satisfaction With BOTOX® Cosmetic Treatment in Facial Rhytides,Completed,Interventional,2013-05-01,Allergan,Industry,,,4,Canada,True,Normal Saline; ,,2014-05-02,125.0,4,True,False,False
NCT01781026,Phase 2 Study of Neoadjuvant Vemurafenib in Melanoma Patients With Untreated Brain Metastases,Completed,Interventional,2014-06-01,Yale University,Other,"Genentech, Inc.",Industry,2,United States,True,Vemurafenib; ,,2015-03-10,2.0,2,True,False,False
NCT01802515,A Drug Treatment for Cocaine Users Who Are Also on Methadone Maintenance Treatment,Completed,Interventional,2014-03-01,Yale University,Other,,,,United States,True,"Atomoxetine, low dose; Atomoxetine, high dose; Placebo; ",,,14.0,5,True,True,False
NCT01830140,A Safety Study of Bimatoprost in Patients With Glaucoma or Ocular Hypertension,Completed,Interventional,2014-05-01,Allergan,Industry,,,3,United States,True,Bimatoprost 0.01%; Bimatoprost 0.03%; ,,2015-04-21,466.0,3,True,False,False
NCT01833130,Use of a Treatment Benefit Questionnaire in Patients With Chronic Migraine Treated With OnabotulinumtoxinA (BOTOX®),Completed,Interventional,2014-09-01,Allergan,Industry,,,4,United States,True,Normal saline (placebo); ,,2015-09-18,52.0,4,True,False,False
NCT01833741,A Study of LUMIGAN® RC in the Clinical Setting,Completed,Interventional,2011-03-01,Allergan,Industry,,,4,Canada,True,Bimatoprost 0.01%; ,,2013-07-09,1137.0,4,True,False,False
NCT01844388,A Study to Compare a New Eye Drop Formulation With Refresh Contacts®,Completed,Interventional,2013-12-01,Allergan,Industry,,,3,United States,True,carboxymethylcellulose based eye drop formula; carboxymethylcellulose sodium based eye drop solution; ,,2014-09-25,365.0,3,True,False,False
NCT01863251,Atomoxetine for ATS and Opioid Dependence During Buprenorphine Maintenance Treatment in Malaysia,Completed,Interventional,2014-08-01,Yale University,Other,,,2,Malaysia,True,Atomoxetine; ,,,100.0,2,True,True,False
NCT01863953,A Safety and Efficacy Study of Fixed-Combination Bimatoprost and Brimonidine in Chronic Glaucoma or Ocular Hypertension,Completed,Interventional,2013-12-01,Allergan,Industry,,,2,United States,True,Fixed-Combination Bimatoprost/Brimonidine; Bimatoprost Ophthalmic Solution 0.01%; Vehicle Ophthalmic Solution; Brimonidine Tartrate Ophthalmic Solution 0.2%; ,,2015-01-16,112.0,2,True,False,False
NCT01870895,A Study to Assess the Efficacy and Safety of YM060 in Female Patients With Diarrhea-predominant Irritable Bowel Syndrome (IBS),Completed,Interventional,2014-02-01,Astellas Pharma Inc,Industry,,,3,Japan,True,YM060; Placebo; ,,,577.0,3,True,False,True
NCT01881126,An Efficacy and Safety Study of Bimatoprost 0.01% Alone Compared With Travoprost 0.004% and Timolol 0.5% in Subjects With Glaucoma or Ocular Hypertension,Completed,Interventional,2014-10-01,Allergan,Industry,,,4,Canada,True,bimatoprost 0.01%; travatan 0.004%; timolol 0.5%; hypromellose 0.3%; ,,2015-10-27,93.0,4,True,False,False
NCT01886690,A Study to Compare the Safety and Efficacy of a New Eye Drop Formulation With REFRESH PLUS® in Participants Following LASIK Refractive Surgery,Completed,Interventional,2014-08-01,Allergan,Industry,,,3,Australia Canada,True,carboxymethylcellulose sodium based new eye drop formulation; carboxymethylcellulose sodium based eye drops; ,,2015-09-03,148.0,3,True,False,False
NCT01888445,A Study to Investigate the Effect of ASP1517 After Intermittent Oral Dosing in Dialysis Chronic Kidney Disease Patients With Anemia Compared With Darbepoetin as a Reference Drug,Completed,Interventional,2014-09-01,Astellas Pharma Inc,Industry,,,2,Japan,True,ASP1517; darbepoetin alfa; ,,,130.0,2,True,True,False
NCT01903720,A Safety and Efficacy Study of OZURDEX® in Macular Edema Associated With Branch Retinal Vein Occlusion,Completed,Interventional,2014-09-01,Allergan,Industry,,,4,"Korea, Republic of",True,dexamethasone implant; ,,2016-06-10,71.0,4,True,False,False
NCT01904721,A Safety and Efficacy Study of Bimatoprost in Men With Androgenic Alopecia (AGA),Completed,Interventional,2014-09-01,Allergan,Industry,,,2,United States,True,Bimatoprost Solution 1; Bimatoprost Solution 2; Bimatoprost Vehicle; ,,2015-11-04,244.0,2,True,False,False
NCT01964183,Post-marketing Study to Evaluate the Effect of Mirabegron on the Plasma Concentration of Tolterodine,Completed,Interventional,2013-08-01,Astellas Pharma Inc,Industry,,,4,Japan,True,tolterodine; mirabegron; ,,,24.0,4,True,True,False
NCT02003534,A Study of 0.15% Brimonidine Tartrate in Patients With Primary Open Angle Glaucoma and Ocular Hypertension,Completed,Interventional,2013-02-01,Allergan,Industry,,,4,China,True,0.15% Brimonidine Tartrate; ,,2014-06-24,376.0,4,True,False,False
NCT02020512,A Study of 0.03% Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension,Completed,Interventional,2012-12-01,Allergan,Industry,,,4,China,True,0.03% Bimatoprost; ,,2014-06-24,87.0,4,True,False,False
NCT02028754,A Study of Sodium Carboxymethylcellulose for Post Cataract Surgery Dry Eye Symptoms,Completed,Interventional,2013-05-01,Allergan,Industry,,,4,China,True,Sodium Carboxymethylcellulose; Levofloxacin; Prednisolone; ,,2014-03-19,180.0,4,True,False,False
NCT02032407,A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris,Completed,Interventional,2014-06-01,Allergan,Industry,,,4,United States,True,Dapsone Gel; ,,2015-06-15,68.0,4,True,False,False
NCT02038868,A Study to Evaluate the Efficacy and Safety of ASP4901 in Patients With Benign Prostate Hyperplasia,Completed,Interventional,2014-04-01,Astellas Pharma Inc,Industry,,,2,Japan,True,ASP4901; Tamsulosin; Placebo; ,,,320.0,2,True,True,False
NCT02061683,A Study of Bimatoprost in the Treatment of Primary Open Angle Glaucoma and Ocular Hypertension,Completed,Interventional,2011-06-01,Allergan,Industry,,,4,China,True,Bimatoprost 0.03%; ,,2014-05-19,263.0,4,True,False,False
NCT02082262,AGN-229666 Ophthalmic Solution for the Treatment of Seasonal or Perennial Allergic Conjunctivitis,Completed,Interventional,2014-07-01,Allergan,Industry,,,3,Japan,True,AGN-229666; ,,2015-09-08,140.0,3,True,False,False
NCT02121847,Investigation of Maintaining Visual Performance Achieved With Cyclosporine Therapy,Completed,Interventional,2014-09-01,Allergan,Industry,,,4,United States,True,cyclosporine 0.05% ophthalmic emulsion; carboxymethylcellulose-based lubricant eye drops; ,,2015-12-07,40.0,4,True,False,False
NCT02197806,Safety and Efficacy of AGN-199201 and AGN-190584 in Patients With Presbyopia,Completed,Interventional,2014-10-01,Allergan,Industry,,,2,United States,True,AGN-199201; AGN-190584; AGN-199201 Vehicle; ,,2015-10-30,65.0,2,True,False,False
NCT02432053,A Study to Demonstrate Safety and Efficacy of Advagraf in Patients Undergoing Kidney or Liver Transplantation in India,Completed,Interventional,2013-05-01,Astellas Pharma Inc,Industry,,,4,India,True,Advagraf; ,,,92.0,4,True,True,False
NCT02586246,Long-term Treatment Study of CDP870 Self-injection in Patients With Active Rheumatoid Arthritis Who Are Participating in the Long-term Treatment Studies (Study 275-08-002 or Study 275-08-004) of CDP870,Completed,Interventional,2013-05-01,Astellas Pharma Inc,Industry,UCB Japan Co. Ltd.,Industry,3,Japan,True,CDP870; ,,,86.0,3,True,True,False
NCT02658188,Long-term Efficacy and Safety of Gabapentin Enacarbil in Japanese Restless Legs Syndrome Patients,Completed,Interventional,2009-04-01,Astellas Pharma Inc,Industry,,,3,Japan,True,ASP8825; ,,,182.0,3,True,True,False
NCT02667470,Reproducibility Study of OABSS and Its Response to Treatment,Completed,Interventional,2013-05-01,Astellas Pharma Inc,Industry,,,4,Thailand,True,Solifenacin; ,,,50.0,4,True,True,False
NCT02753894,Dose Range-finding Study of ASP1585 in Chronic Kidney Disease Patients on Hemodialysis With Hyperphosphatemia,Completed,Interventional,2008-06-01,Astellas Pharma Inc,Industry,,,2,Japan,True,ASP1585; ,,,73.0,2,True,True,False
